#BEGIN_DRUGCARD DB04233

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
41323

# Chemical_Formula:
C16H34O5

# Chemical_IUPAC_Name:
3,6,9,12-tetraoxaicosan-1-ol

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
(Hydroxyethyloxy)Tri(Ethyloxy)Octane

# HET_ID:
C8E

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C16H34O5/c1-2-3-4-5-6-7-9-18-11-13-20-15-16-21-14-12-19-10-8-17/h17H,2-16H2,1H3

# InChI_Key:
InChIKey=FEOZZFHAVXYAMB-UHFFFAOYSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
4233

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
306.4382

# Molecular_Weight_Mono:
306.240624198

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
6PRN

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
2.45

# Predicted_LogS:
-4.1

# Predicted_Water_Solubility:
2.56e-02 g/l

# Primary_Accession_No:
DB04233

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
5414

# PubChem_Substance_ID:
46506525

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT00817

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
CCCCCCCCOCCOCCOCCOCCO

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:23:07 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_10_Cellular_Location:
Membrane
multi-pass membrane protein

# Drug_Target_10_Chromosome_Location:
Not Available

# Drug_Target_10_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_10_Essentiality:
Non-Essential

# Drug_Target_10_GenAtlas_ID:
RHO

# Drug_Target_10_GenBank_ID_Gene:
U49742

# Drug_Target_10_GenBank_ID_Protein:
1236137

# Drug_Target_10_GeneCard_ID:
RHO

# Drug_Target_10_Gene_Name:
RHO

# Drug_Target_10_Gene_Sequence:
>1047 bp
ATGAATGGCACAGAAGGCCCTAACTTCTACGTGCCCTTCTCCAATGCGACGGGTGTGGTA
CGCAGCCCCTTCGAGTACCCACAGTACTACCTGGCTGAGCCATGGCAGTTCTCCATGCTG
GCCGCCTACATGTTTCTGCTGATCGTGCTGGGCTTCCCCATCAACTTCCTCACGCTCTAC
GTCACCGTCCAGCACAAGAAGCTGCGCACGCCTCTCAACTACATCCTGCTCAACCTAGCC
GTGGCTGACCTCTTCATGGTCCTAGGTGGCTTCACCAGCACCCTCTACACCTCTCTGCAT
GGATACTTCGTCTTCGGGCCCACAGGATGCAATTTGGAGGGCTTCTTTGCCACCCTGGGC
GGTGAAATTGCCCTGTGGTCCTTGGTGGTCCTGGCCATCGAGCGGTACGTGGTGGTGTGT
AAGCCCATGAGCAACTTCCGCTTCGGGGAGAACCATGCCATCATGGGCGTTGCCTTCACC
TGGGTCATGGCGCTGGCCTGCGCCGCACCCCCACTCGCCGGCTGGTCCAGGTACATCCCC
GAGGGCCTGCAGTGCTCGTGTGGAATCGACTACTACACGCTCAAGCCGGAGGTCAACAAC
GAGTCTTTTGTCATCTACATGTTCGTGGTCCACTTCACCATCCCCATGATTATCATCTTT
TTCTGCTATGGGCAGCTCGTCTTCACCGTCAAGGAGGCCGCTGCCCAGCAGCAGGAGTCA
GCCACCACACAGAAGGCAGAGAAGGAGGTCACCCGCATGGTCATCATCATGGTCATCGCT
TTCCTGATCTGCTGGGTGCCCTACGCCAGCGTGGCATTCTACATCTTCACCCACCAGGGC
TCCAACTTCGGTCCCATCTTCATGACCATCCCAGCGTTCTTTGCCAAGAGCGCCGCCATC
TACAACCCTGTCATCTATATCATGATGAACAAGCAGTTCCGGAACTGCATGCTCACCACC
ATCTGCTGCGGCAAGAACCCACTGGGTGACGATGAGGCCTCTGCTACCGTGTCCAAGACG
GAGACGAGCCAGGTGGCCCCGGCCTAA

# Drug_Target_10_General_Function:
Involved in rhodopsin-like receptor activity

# Drug_Target_10_General_References:
1302614	Farrar GJ, Findlay JB, Kumar-Singh R, Kenna P, Humphries MM, Sharpe E, Humphries P: Autosomal dominant retinitis pigmentosa: a novel mutation in the rhodopsin gene in the original 3q linked family. Hum Mol Genet. 1992 Dec;1(9):769-71.
1391967	Fujiki K, Hotta Y, Hayakawa M, Sakuma H, Shiono T, Noro M, Sakuma T, Tamai M, Hikiji K, Kawaguchi R, et al.: Point mutations of rhodopsin gene found in Japanese families with autosomal dominant retinitis pigmentosa (ADRP). Jpn J Hum Genet. 1992 Jun;37(2):125-32.
1833777	Dryja TP, Hahn LB, Cowley GS, McGee TL, Berson EL: Mutation spectrum of the rhodopsin gene among patients with autosomal dominant retinitis pigmentosa. Proc Natl Acad Sci U S A. 1991 Oct 15;88(20):9370-4.
1840561	Gal A, Artlich A, Ludwig M, Niemeyer G, Olek K, Schwinger E, Schinzel A: Pro-347-Arg mutation of the rhodopsin gene in autosomal dominant retinitis pigmentosa. Genomics. 1991 Oct;11(2):468-70.
1862076	Sung CH, Davenport CM, Hennessey JC, Maumenee IH, Jacobson SG, Heckenlively JR, Nowakowski R, Fishman G, Gouras P, Nathans J: Rhodopsin mutations in autosomal dominant retinitis pigmentosa. Proc Natl Acad Sci U S A. 1991 Aug 1;88(15):6481-5.
1897520	Sheffield VC, Fishman GA, Beck JS, Kimura AE, Stone EM: Identification of novel rhodopsin mutations associated with retinitis pigmentosa by GC-clamped denaturing gradient gel electrophoresis. Am J Hum Genet. 1991 Oct;49(4):699-706.
1985460	Inglehearn CF, Bashir R, Lester DH, Jay M, Bird AC, Bhattacharya SS: A 3-bp deletion in the rhodopsin gene in a family with autosomal dominant retinitis pigmentosa. Am J Hum Genet. 1991 Jan;48(1):26-30.
2137202	Dryja TP, McGee TL, Reichel E, Hahn LB, Cowley GS, Yandell DW, Sandberg MA, Berson EL: A point mutation of the rhodopsin gene in one form of retinitis pigmentosa. Nature. 1990 Jan 25;343(6256):364-6.
2215617	Dryja TP, McGee TL, Hahn LB, Cowley GS, Olsson JE, Reichel E, Sandberg MA, Berson EL: Mutations within the rhodopsin gene in patients with autosomal dominant retinitis pigmentosa. N Engl J Med. 1990 Nov 8;323(19):1302-7.
2239971	Farrar GJ, Kenna P, Redmond R, McWilliam P, Bradley DG, Humphries MM, Sharp EM, Inglehearn CF, Bashir R, Jay M, et al.: Autosomal dominant retinitis pigmentosa: absence of the rhodopsin proline----histidine substitution (codon 23) in pedigrees from Europe. Am J Hum Genet. 1990 Dec;47(6):941-5.
6589631	Nathans J, Hogness DS: Isolation and nucleotide sequence of the gene encoding human rhodopsin. Proc Natl Acad Sci U S A. 1984 Aug;81(15):4851-5.
7633434	Macke JP, Hennessey JC, Nathans J: Rhodopsin mutation proline347-to-alanine in a family with autosomal dominant retinitis pigmentosa indicates an important role for proline at position 347. Hum Mol Genet. 1995 Apr;4(4):775-6.
7846071	Sieving PA, Richards JE, Naarendorp F, Bingham EL, Scott K, Alpern M: Dark-light: model for nightblindness from the human rhodopsin Gly-90-->Asp mutation. Proc Natl Acad Sci U S A. 1995 Jan 31;92(3):880-4.
7981701	Fuchs S, Kranich H, Denton MJ, Zrenner E, Bhattacharya SS, Humphries P, Gal A: Three novel rhodopsin mutations (C110F, L131P, A164V) in patients with autosomal dominant retinitis pigmentosa. Hum Mol Genet. 1994 Jul;3(7):1203.
7987326	Antinolo G, Sanchez B, Borrego S, Rueda T, Chaparro P, Cabeza JC: Identification of a new mutation at codon 171 of rhodopsin gene causing autosomal dominant retinitis pigmentosa. Hum Mol Genet. 1994 Aug;3(8):1421.
7987331	Souied E, Gerber S, Rozet JM, Bonneau D, Dufier JL, Ghazi I, Philip N, Soubrane G, Coscas G, Munnich A, et al.: Five novel missense mutations of the rhodopsin gene in autosomal dominant retinitis pigmentosa. Hum Mol Genet. 1994 Aug;3(8):1433-4.
7987385	Kumaramanickavel G, Maw M, Denton MJ, John S, Srikumari CR, Orth U, Oehlmann R, Gal A: Missense rhodopsin mutation in a family with recessive RP. Nat Genet. 1994 Sep;8(1):10-1.
8045708	Rosas DJ, Roman AJ, Weissbrod P, Macke JP, Nathans J: Autosomal dominant retinitis pigmentosa in a large family: a clinical and molecular genetic study. Invest Ophthalmol Vis Sci. 1994 Jul;35(8):3134-44.
8076945	Reig C, Antich J, Gean E, Garcia-Sandoval B, Ramos C, Ayuso C, Carballo M: Identification of a novel rhodopsin mutation (Met-44-Thr) in a simplex case of retinitis pigmentosa. Hum Genet. 1994 Sep;94(3):283-6.
8081400	al-Maghtheh M, Inglehearn C, Lunt P, Jay M, Bird A, Bhattacharya S: Two new rhodopsin transversion mutations (L40R; M216K) in families with autosomal dominant retinitis pigmentosa. Hum Mutat. 1994;3(4):409-10.
8088850	Vaithinathan R, Berson EL, Dryja TP: Further screening of the rhodopsin gene in patients with autosomal dominant retinitis pigmentosa. Genomics. 1994 May 15;21(2):461-3.
8317502	Macke JP, Davenport CM, Jacobson SG, Hennessey JC, Gonzalez-Fernandez F, Conway BP, Heckenlively J, Palmer R, Maumenee IH, Sieving P, et al.: Identification of novel rhodopsin mutations responsible for retinitis pigmentosa: implications for the structure and function of rhodopsin. Am J Hum Genet. 1993 Jul;53(1):80-9.
8353500	Kranich H, Bartkowski S, Denton MJ, Krey S, Dickinson P, Duvigneau C, Gal A: Autosomal dominant 'sector' retinitis pigmentosa due to a point mutation predicting an Asn-15-Ser substitution of rhodopsin. Hum Mol Genet. 1993 Jun;2(6):813-4.
8358437	Dryja TP, Berson EL, Rao VR, Oprian DD: Heterozygous missense mutation in the rhodopsin gene as a cause of congenital stationary night blindness. Nat Genet. 1993 Jul;4(3):280-3.
8401533	al-Maghtheh M, Gregory C, Inglehearn C, Hardcastle A, Bhattacharya S: Rhodopsin mutations in autosomal dominant retinitis pigmentosa. Hum Mutat. 1993;2(4):249-55.
8554077	Souied E, Soubrane G, Benlian P, Coscas GJ, Gerber S, Munnich A, Kaplan J: Retinitis punctata albescens associated with the Arg135Trp mutation in the rhodopsin gene. Am J Ophthalmol. 1996 Jan;121(1):19-25.
9452035	Goliath R, Bardien S, September A, Martin R, Ramesar R, Greenberg J: Rhodopsin mutation G109R in a family with autosomal dominant retinitis pigmentosa. Hum Mutat. 1998;Suppl 1:S40-1.
9888392	al-Jandal N, Farrar GJ, Kiang AS, Humphries MM, Bannon N, Findlay JB, Humphries P, Kenna PF: A novel mutation within the rhodopsin gene (Thr-94-Ile) causing autosomal dominant congenital stationary night blindness. Hum Mutat. 1999;13(1):75-81.

# Drug_Target_10_HGNC_ID:
HGNC:10012

# Drug_Target_10_HPRD_ID:
01584

# Drug_Target_10_ID:
2207

# Drug_Target_10_Locus:
3q21-q24

# Drug_Target_10_Molecular_Weight:
38893

# Drug_Target_10_Name:
Rhodopsin

# Drug_Target_10_Number_of_Residues:
348

# Drug_Target_10_PDB_ID:
1LN6

# Drug_Target_10_Pathway:
Not Available

# Drug_Target_10_Pfam_Domain_Function:
PF00001	7tm_1

# Drug_Target_10_Protein_Sequence:
>Rhodopsin
MNGTEGPNFYVPFSNATGVVRSPFEYPQYYLAEPWQFSMLAAYMFLLIVLGFPINFLTLY
VTVQHKKLRTPLNYILLNLAVADLFMVLGGFTSTLYTSLHGYFVFGPTGCNLEGFFATLG
GEIALWSLVVLAIERYVVVCKPMSNFRFGENHAIMGVAFTWVMALACAAPPLAGWSRYIP
EGLQCSCGIDYYTLKPEVNNESFVIYMFVVHFTIPMIIIFFCYGQLVFTVKEAAAQQQES
ATTQKAEKEVTRMVIIMVIAFLICWVPYASVAFYIFTHQGSNFGPIFMTIPAFFAKSAAI
YNPVIYIMMNKQFRNCMLTTICCGKNPLGDDEASATVSKTETSQVAPA

# Drug_Target_10_Reaction:
Not Available

# Drug_Target_10_Signals:
None

# Drug_Target_10_Specific_Function:
Visual pigments are the light-absorbing molecules that mediate vision. They consist of an apoprotein, opsin, covalently linked to cis-retinal

# Drug_Target_10_SwissProt_ID:
P08100

# Drug_Target_10_SwissProt_Name:
OPSD_HUMAN

# Drug_Target_10_Synonyms:
Opsin-2

# Drug_Target_10_Theoretical_pI:
6.64

# Drug_Target_10_Transmembrane_Regions:
37-61
74-98
114-133
153-176
203-230
253-276
285-309

# Drug_Target_11_Cellular_Location:
Not Available

# Drug_Target_11_Chromosome_Location:
Not Available

# Drug_Target_11_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_11_Essentiality:
Non-Essential

# Drug_Target_11_GenAtlas_ID:
Not Available

# Drug_Target_11_GenBank_ID_Gene:
BA000022

# Drug_Target_11_GenBank_ID_Protein:
Not Available

# Drug_Target_11_GeneCard_ID:
Not Available

# Drug_Target_11_Gene_Name:
sll1541

# Drug_Target_11_Gene_Sequence:
>1473 bp
TCAAGTCTGGGCCCAGGAACCGTGCAGGGGATAGGGAATGTGATGCTTTAACTTCAAAGT
GGCGATCGCCGGAGCAGTAATGTCCTGAGCATCAAGAATCACTAGTTCGGAACGGTGCAA
ATCAGCTTTATAAATCAAGCAGAGCAACCAACCATCATCTTCAGCCACGCCACCGGGTCG
GGGCACAAAAATAGGTTCCCCGGCAAAACCATGGGGGGCAAAGGAACGTAGAGTTTCAGT
GCCGGACTCTAGATCTACTTTGAGAATGGCCTGAAGGGGAGCATTGCCTGTGCTATGGTG
TGCGGCTCCCATGTAAACATAGCGATATGGACGGCCAACCTGCTGGGGATGGACAACGGG
AAACTCGCAACAACGACTAACCATTAACTGTTTTTCCACCGTGGCTGCTGCGGGATCAAT
GGTGAAACGCCATAACTGTCCGGGATCTAAATTATCGAAATTCGTACTACGAAAATCCCC
ATCGGTGTCTACCTGGGGCAGGGAATTGTAACAAATGGAATCGAGGATTATTTTGCCATT
TTCCTCAAAAGCGTTGGCATGGTGAAAAACAAAGCCTGCCTGTACCGGAATTCTTTTTAT
TTCTCCACCGTCCCTAGGAACGAGAATAATTTGAGCAGGTTTATCGGGATGAAATTGCAC
ACATTCCCCTGCTCCTCGCAAACCGAAAAGGTAGGGTAACCCGTTGAGAGTAACGTTATT
TTGCAGAAAAATGGCGTAATGGGGCGTGATCGCAAAATCATGAATAAAAGCAAAACCAGG
AAAAGTTTCAGTTTTTTGCCGCAACAATTTACCCTGGGGGTCTAGCTCTAACAGGGTGAG
GGTACTGCTCAAGCTGGATTTAATTGAAAAGGTCACATAGCAGGGTTGGCCCCCATCAAA
AGTTGAAGCCGGATCAATGCGGGGATGGGCCGACAGGGGTTGCCCTTCCGCAAGAATGCC
GCCCAAATCATCCAACCCAATGGTTGCTAAGTTTGATGGTTCCAAGCGATGGGGTTGTCC
CCCTTCCCATAGGGCCAAGAGGCGATCGCCCCAGTAGGTAATGTTGGTGTTGGCAATGTT
TTTTAGCCGTAAGTCAAAGATAGTTTTGAGCCAGCCCCCCGCCGGTTGGGAACCAAAGAC
GCCCCGATAGATCATTTTTCCCGCTTTTTGCTCTTCCACGTAACCCTGGGTGCGGACAAA
TTTGCTCTGGAAATGTACTCGACCGTCCCCAGGAAATTTAAAGGCTGTCACCATGCCGTC
CCCGTCAAAGGGATGCTTCAAAGGGCGATCGCCAATTTCCAATAATCCAGGGCCGTTGCG
ATAGAGCGTTCCCTGGAGGTCTGGGGGTATGCTCCCTTCCACGTCTTCGACCCAATAATC
CCACTCCTGGGGCTGGGACTGGTAACCTCTCAGCCAATCCTGCGGACTGTAGGAGCGCTG
CGATGGGGAACTGGTTGGGGGGGAAGTGACCAT

# Drug_Target_11_General_Function:
Secondary metabolites biosynthesis, transport and catabolism

# Drug_Target_11_General_References:
8905231	Kaneko T, Sato S, Kotani H, Tanaka A, Asamizu E, Nakamura Y, Miyajima N, Hirosawa M, Sugiura M, Sasamoto S, Kimura T, Hosouchi T, Matsuno A, Muraki A, Nakazaki N, Naruo K, Okumura S, Shimpo S, Takeuchi C, Wada T, Watanabe A, Yamada M, Yasuda M, Tabata S: Sequence analysis of the genome of the unicellular cyanobacterium Synechocystis sp. strain PCC6803. II. Sequence determination of the entire genome and assignment of potential protein-coding regions. DNA Res. 1996 Jun 30;3(3):109-36.

# Drug_Target_11_HGNC_ID:
Not Available

# Drug_Target_11_HPRD_ID:
Not Available

# Drug_Target_11_ID:
4627

# Drug_Target_11_Locus:
Not Available

# Drug_Target_11_Molecular_Weight:
54287

# Drug_Target_11_Name:
Lignostilbene-alpha,beta-dioxygenase

# Drug_Target_11_Number_of_Residues:
490

# Drug_Target_11_PDB_ID:
2BIX

# Drug_Target_11_Pathway:
Not Available

# Drug_Target_11_Pfam_Domain_Function:
PF03055	RPE65

# Drug_Target_11_Protein_Sequence:
>Lignostilbene-alpha,beta-dioxygenase
MVTSPPTSSPSQRSYSPQDWLRGYQSQPQEWDYWVEDVEGSIPPDLQGTLYRNGPGLLEI
GDRPLKHPFDGDGMVTAFKFPGDGRVHFQSKFVRTQGYVEEQKAGKMIYRGVFGSQPAGG
WLKTIFDLRLKNIANTNITYWGDRLLALWEGGQPHRLEPSNLATIGLDDLGGILAEGQPL
SAHPRIDPASTFDGGQPCYVTFSIKSSLSSTLTLLELDPQGKLLRQKTETFPGFAFIHDF
AITPHYAIFLQNNVTLNGLPYLFGLRGAGECVQFHPDKPAQIILVPRDGGEIKRIPVQAG
FVFHHANAFEENGKIILDSICYNSLPQVDTDGDFRSTNFDNLDPGQLWRFTIDPAAATVE
KQLMVSRCCEFPVVHPQQVGRPYRYVYMGAAHHSTGNAPLQAILKVDLESGTETLRSFAP
HGFAGEPIFVPRPGGVAEDDGWLLCLIYKADLHRSELVILDAQDITAPAIATLKLKHHIP
YPLHGSWAQT

# Drug_Target_11_Reaction:
Not Available

# Drug_Target_11_Signals:
None

# Drug_Target_11_Specific_Function:
Not Available

# Drug_Target_11_SwissProt_ID:
P74334

# Drug_Target_11_SwissProt_Name:
ACOX_SYNY3

# Drug_Target_11_Synonyms:
Not Available

# Drug_Target_11_Theoretical_pI:
6.16

# Drug_Target_11_Transmembrane_Regions:
None

# Drug_Target_12_Cellular_Location:
Cell outer membrane

# Drug_Target_12_Chromosome_Location:
Not Available

# Drug_Target_12_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_12_Essentiality:
Essential

# Drug_Target_12_GenAtlas_ID:
Not Available

# Drug_Target_12_GenBank_ID_Gene:
U49400

# Drug_Target_12_GenBank_ID_Protein:
1842218

# Drug_Target_12_GeneCard_ID:
ompG

# Drug_Target_12_Gene_Name:
ompG

# Drug_Target_12_Gene_Sequence:
>969 bp
ATGGCTCAGCTTTCGTTACAACATATTCAAAAAATCTACGATAACCAGGTGCATGTGGTG
AAGGACTTCAACCTGGAAATTGCCGATAAAGAGTTCATCGTGTTTGTCGCCGCGTCGGGC
TGCGGTAAGTCGACCACCCTGCGCATGATTGCCGGGCTTGAGGAGATCAGCGGCGGCGAT
CTGTTGATCGACGGCAAACGAATGAATGACGTTCCAGCCAAAGCACGCAATATAGCGATG
GTGTTCCAGAACTACGCGTTGTATCCGCATATGACGGTTTACGACAACATGGCGTTTGGT
CTGAAGATGCAAAAAATCGCCAAAGAGGTGATTGATGAGCGGGTGAACTGGGCGGCGCAA
ATTCTCGGCCTGCGTGAGTACCTGAAACGTAAGCCGGGGGCGCTTTCCGGCGGGCAACGT
CAGCGAGTGGCGCTTGGGCGGGCGATTGTACGCGAAGCGGGCGTGTTTTTAATGGATGAA
CCGCTCTCTAACCTTGATGCCAAGCTGCGCGTGCAAATGCGCGCAGAGATCAGCAAGCTG
CATCAGAAACTGAACACCACCATGATCTACGTGACCCACGATCAGACCGAAGCGATGACC
ATGGCGACGCGGATTGTGATTATGAAAGACGGGATTGTTCAGCAAGTAGGTGCGCCGAAA
ACCGTTTATAACCAACCCGCGAATATGTTTGTTTCCGGATTTATTGGATCACCAGCGATG
AATTTTATTCGCGGCACGATCGATGGCGATAAATTCGTTACGGAAACGCTTAAATTAACC
ATTCCCGAAGAGAAATTAGCGGTTCTGAAAACACAGGAAAGTTTGCATAAGCCCATCGTG
ATGGGAATACGACCGGAAGATATTCATCCGGACGCGCAAGAGGAAAATAACATTTCCGCC
AAAATTAGCGTGGCAGAATTAACCGGTGCGGAATTTATGCTCTACACCACGGTTGGGGGC
ACGAGTTAG

# Drug_Target_12_General_Function:
Involved in ion transport

# Drug_Target_12_General_References:
11758943	Chen MH, Takeda S, Yamada H, Ishii Y, Yamashino T, Mizuno T: Characterization of the RcsC-->YojN-->RcsB phosphorelay signaling pathway involved in capsular synthesis in Escherichia coli. Biosci Biotechnol Biochem. 2001 Oct;65(10):2364-7.
16738553	Hayashi K, Morooka N, Yamamoto Y, Fujita K, Isono K, Choi S, Ohtsubo E, Baba T, Wanner BL, Mori H, Horiuchi T: Highly accurate genome sequences of Escherichia coli K-12 strains MG1655 and W3110. Mol Syst Biol. 2006;2:2006.0007. Epub 2006 Feb 21.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-62.
9721282	Fajardo DA, Cheung J, Ito C, Sugawara E, Nikaido H, Misra R: Biochemistry and regulation of a novel Escherichia coli K-12 porin protein, OmpG, which produces unusually large channels. J Bacteriol. 1998 Sep;180(17):4452-9.

# Drug_Target_12_HGNC_ID:
Not Available

# Drug_Target_12_HPRD_ID:
Not Available

# Drug_Target_12_ID:
6438

# Drug_Target_12_Locus:
Not Available

# Drug_Target_12_Molecular_Weight:
34913.0

# Drug_Target_12_Name:
Outer membrane protein G

# Drug_Target_12_Number_of_Residues:
301

# Drug_Target_12_PDB_ID:
Not Available

# Drug_Target_12_Pathway:
Not Available

# Drug_Target_12_Pfam_Domain_Function:
PF09381	Porin_OmpG

# Drug_Target_12_Protein_Sequence:
>Outer membrane protein G
MKKLLPCTALVMCAGMACAQAEERNDWHFNIGAMYEIENVEGYGEDMDGLAEPSVYFNAA
NGPWRIALAYYQEGPVDYSAGKRGTWFDRPELEVHYQFLENDDFSFGLTGGFRNYGYHYV
DEPGKDTANMQRWKIAPDWDVKLTDDLRFNGWLSMYKFANDLNTTGYADTRVETETGLQY
TFNETVALRVNYYLERGFNMDDSRNNGEFSTQEIRAYLPLTLGNHSVTPYTRIGLDRWSN
WDWQDDIEREGHDFNRVGLFYGYDFQNGLSVSLEYAFEWQDHDEGDSDKFHYAGVGVNYS
F

# Drug_Target_12_Reaction:
Not Available

# Drug_Target_12_Signals:
1-21

# Drug_Target_12_Specific_Function:
May act as a regulator of the RCS-phosphorelay signal transduction pathway

# Drug_Target_12_SwissProt_ID:
P76045

# Drug_Target_12_SwissProt_Name:
OMPG_ECOLI

# Drug_Target_12_Synonyms:
Not Available

# Drug_Target_12_Theoretical_pI:
4.21

# Drug_Target_12_Transmembrane_Regions:
27-35
47-57
64-72
89-98
104-112
129-136
149-158
172-182
186-195
201-209
213-222
230-238
240-248
254-265
269-279
289-300

# Drug_Target_13_Cellular_Location:
Cell outer membrane

# Drug_Target_13_Chromosome_Location:
Not Available

# Drug_Target_13_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_13_Essentiality:
Essential

# Drug_Target_13_GenAtlas_ID:
Not Available

# Drug_Target_13_GenBank_ID_Gene:
X13583

# Drug_Target_13_GenBank_ID_Protein:
43208

# Drug_Target_13_GeneCard_ID:
ompW

# Drug_Target_13_Gene_Name:
ompW

# Drug_Target_13_Gene_Sequence:
>180 bp
ATGGCCGAACATCGTGGTGGTTCAGGAAATTTCGCCGAAGACCGTGAGAAGGCATCCGAC
GCAGGCCGTAAAGGCGGTCAGCATAGCGGCGGTAATTTTAAAAATGATCCGCAACGCGCA
TCTGAAGCGGGTAAAAAAGGCGGTCAACAAAGCGGTGGTAATAAATCAGGCAAATCCTGA

# Drug_Target_13_General_Function:
Cell wall/membrane/envelope biogenesis

# Drug_Target_13_General_References:
10348872	Pilsl H, Smajs D, Braun V: Characterization of colicin S4 and its receptor, OmpW, a minor protein of the Escherichia coli outer membrane. J Bacteriol. 1999 Jun;181(11):3578-81.
16738553	Hayashi K, Morooka N, Yamamoto Y, Fujita K, Isono K, Choi S, Ohtsubo E, Baba T, Wanner BL, Mori H, Horiuchi T: Highly accurate genome sequences of Escherichia coli K-12 strains MG1655 and W3110. Mol Syst Biol. 2006;2:2006.0007. Epub 2006 Feb 21.
3058546	Stoltzfus A, Leslie JF, Milkman R: Molecular evolution of the Escherichia coli chromosome. I. Analysis of structure and natural variation in a previously uncharacterized region between trp and tonB. Genetics. 1988 Oct;120(2):345-58.
9097039	Aiba H, Baba T, Hayashi K, Inada T, Isono K, Itoh T, Kasai H, Kashimoto K, Kimura S, Kitakawa M, Kitagawa M, Makino K, Miki T, Mizobuchi K, Mori H, Mori T, Motomura K, Nakade S, Nakamura Y, Nashimoto H, Nishio Y, Oshima T, Saito N, Sampei G, Horiuchi T, et al.: A 570-kb DNA sequence of the Escherichia coli K-12 genome corresponding to the 28.0-40.1 min region on the linkage map. DNA Res. 1996 Dec 31;3(6):363-77.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-62.
9629924	Molloy MP, Herbert BR, Walsh BJ, Tyler MI, Traini M, Sanchez JC, Hochstrasser DF, Williams KL, Gooley AA: Extraction of membrane proteins by differential solubilization for separation using two-dimensional gel electrophoresis. Electrophoresis. 1998 May;19(5):837-44.

# Drug_Target_13_HGNC_ID:
Not Available

# Drug_Target_13_HPRD_ID:
Not Available

# Drug_Target_13_ID:
6474

# Drug_Target_13_Locus:
Not Available

# Drug_Target_13_Molecular_Weight:
22927.7

# Drug_Target_13_Name:
Outer membrane protein W

# Drug_Target_13_Number_of_Residues:
212

# Drug_Target_13_PDB_ID:
Not Available

# Drug_Target_13_Pathway:
Not Available

# Drug_Target_13_Pfam_Domain_Function:
PF03922	OmpW

# Drug_Target_13_Protein_Sequence:
>Outer membrane protein W
MKKLTVAALAVTTLLSGSAFAHEAGEFFMRAGSATVRPTEGAGGTLGSLGGFSVTNNTQL
GLTFTYMATDNIGVELLAATPFRHKIGTRATGDIATVHHLPPTLMAQWYFGDASSKFRPY
VGAGINYTTFFDNGFNDHGKEAGLSDLSLKDSWGAAGQVGVDYLINRDWLVNMSVWYMDI
DTTANYKLGGAQQHDSVRLDPWVFMFSAGYRF

# Drug_Target_13_Reaction:
Not Available

# Drug_Target_13_Signals:
1-21

# Drug_Target_13_Specific_Function:
Acts as a receptor for colicin S4

# Drug_Target_13_SwissProt_ID:
P0A915

# Drug_Target_13_SwissProt_Name:
OMPW_ECOLI

# Drug_Target_13_Synonyms:
Not Available

# Drug_Target_13_Theoretical_pI:
6.51

# Drug_Target_13_Transmembrane_Regions:
None

# Drug_Target_14_Cellular_Location:
Not Available

# Drug_Target_14_Chromosome_Location:
Not Available

# Drug_Target_14_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_14_Essentiality:
Essential

# Drug_Target_14_GenAtlas_ID:
Not Available

# Drug_Target_14_GenBank_ID_Gene:
U38617

# Drug_Target_14_GenBank_ID_Protein:
21536216

# Drug_Target_14_GeneCard_ID:
hia

# Drug_Target_14_Gene_Name:
hia

# Drug_Target_14_Gene_Sequence:
>3297 bp
ATGAACAAAATTTTTAACGTTATTTGGAATGTTGTGACTCAAACTTGGGTTGTCGTATCT
GAACTCACTCGCACCCACACCAAATGCGCCTCCGCCACCGTGGCGGTTGCCGTATTGGCA
ACCCTGTTGTCCGCAACGGTTGAGGCGAACAACAATACTCCTGTTACGAATAAGTTGAAG
GCTTATGGCGATGCGAATTTTAATTTCACTAATAATTCGATAGCAGATGCAGAAAAACAA
GTTCAAGAGGCTTATAAAGGTTTATTAAATCTAAATGAAAAAAATGCGAGTGATAAACTG
TTGGTGGAGGACAATACTGCGGCGACCGTAGGCAATTTGCGTAAATTGGGCTGGGTATTG
TCTAGCAAAAACGGCACAAGGAACGAGAAAAGCCAACAAGTCAAACATGCGGATGAAGTG
TTGTTTGAAGGCAAAGGCGGTGTGCAGGTTACTTCCACCTCTGAAAACGGCAAACACACC
ATTACCTTTGCTTTAGCGAAAGACCTTGGTGTGAAAACTGCGACTGTGAGTGATACCTTA
ACGATTGGCGGTGGTGCTGCTGCAGGTGCTACAACAACACCGAAAGTGAATGTAACTAGT
ACAACTGATGGCTTGAAGTTCGCTAAAGATGCTGCGGGTGCTAATGGCGATACTACGGTT
CACTTGAATGGTATTGGTTCAACCTTGACAGACACGCTTGTGGGTTCTCCTGCTACTCAT
ATTGACGGAGGAGATCAAAGTACGCATTACACTCGTGCAGCAAGTATCAAGGATGTCTTG
AATGCGGGTTGGAATATCAAGGGTGTTAAAGCTGGCTCAACAACTGGTCAATCAGAAAAT
GTCGATTTTGTTCATACTTACGATACTGTTGAGTTCTTGAGTGCGGATACAGAGACCACG
ACTGTTACTGTAGATAGCAAAGAAAACGGTAAGAGAACCGAAGTTAAAATCGGTGCGAAG
ACTTCTGTTATCAAAGAAAAAGACGGTAAGTTATTTACTGGAAAAGCTAACAAAGAGACA
AATAAAGTTGATGGTGCTAACGCGACTGAAGATGCAGACGAAGGCAAAGGCTTAGTGACT
GCGAAAGATGTGATTGACGCAGTGAATAAGACTGGTTGGAGAATTAAAACAACCGATGCT
AATGGTCAAAATGGCGACTTCGCAACTGTTGCATCAGGCACAAATGTAACCTTTGCTAGT
GGTAATGGTACAACTGCGACTGTAACTAATGGCACCGATGGTATTACCGTTAAGTATGAT
GCGAAAGTTGGCGACGGCTTAAAACTAGATGGCGATAAAATCGCTGCAGATACGACCGCA
CTTACTGTGAATGATGGTAAGAACGCTAATAATCCGAAAGGTAAAGTGGCTGATGTTGCT
TCAACTGACGAGAAGAAATTGGTTACAGCAAAAGGTTTAGTAACAGCCTTAAACAGTCTA
AGCTGGACTACAACTGCTGCTGAGGCGGACGGTGGTACGCTTGATGGAAATGCAAGTGAG
CAAGAAGTTAAAGCGGGCGATAAAGTAACCTTTAAAGCAGGCAAGAACTTAAAAGTGAAA
CAAGAGGGTGCGAACTTTACTTATTCACTGCAAGATGCTTTAACAGGCTTAACGAGCATT
ACTTTAGGTACAGGAAATAATGGTGCGAAAACTGAAATCAACAAAGACGGCTTAACCATC
ACACCAGCAAATGGTGCGGGTGCAAATAATGCAAACACCATCAGCGTAACCAAAGACGGC
ATTAGTGCGGGCGGTCAGTCGGTTAAAAACGTTGTGAGCGGACTGAAGAAATTTGGTGAT
GCGAATTTCGATCCGCTGACTAGCTCCGCCGACAACTTAACGAAACAAAATGACGATGCC
TATAAAGGCTTGACCAATTTGGATGAAAAAGGTACAGACAAGCAAACTCCAGTTGTTGCC
GACAATACCGCCGCAACCGTGGGCGATTTGCGCGGCTTGGGCTGGGTCATTTCTGCGGAC
AAAACCACAGGCGGCTCAACGGAATATCACGATCAAGTTCGGAATGCGAACGAAGTGAAA
TTCAAAAGCGGCAACGGTATCAATGTTTCCGGTAAAACGGTCAACGGTAGGCGTGAAATT
ACTTTTGAATTGGCTAAAGGTGAAGTGGTTAAATCGAATGAATTTACCGTCAAAGAAACC
AATGGAAAGGAAACGAGCCTGGTTAAAGTTGGCGATAAATATTACAGCAAAGAGGATATT
GACTTAACAACTGGTCAGCCTAAATTAAAAGATGGCAATACAGTTGCTGCGAAATATCAA
GATAAAGGTGGCAAAGTCGTTTCTGTAACGGATAATACTGAAGCTACCATAACCAACAAA
GGTTCTGGCTATGTAACAGGTAACCAAGTGGCAGATGCGATTGCGAAATCAGGCTTTGAG
CTTGGCTTGGCTGATGAAGCTGATGCGAAAGCGGCGTTTGATGATAAGACAAAAGCCTTA
TCTGCTGGTACAACGGAAATTGTAAATGCCCACGATAAAGTCCGTTTTGCTAATGGTTTA
AATACCAAAGTGAGCGCGGCAACGGTGGAAAGCACCGATGCAAACGGCGATAAAGTGACC
ACAACCTTTGTGAAAACCGATGTGGAATTGCCTTTAACGCAAATCTACAATACCGATGCA
AACGGTAAGAAAATCACTAAAGTTGTCAAAGATGGGCAAACTAAATGGTATGAACTGAAT
GCTGACGGTACGGCTGATATGACCAAAGAAGTTACCCTCGGTAACGTGGATTCAGACGGC
AAGAAAGTTGTGAAAGACAACGATGGCAAGTGGTATCACGCCAAAGCTGACGGTACTGCG
GATAAAACCAAAGGCGAAGTGAGCAATGATAAAGTTTCTACCGATGAAAAACACGTTGTC
AGCCTTGATCCAAATGATCAATCAAAAGGTAAAGGTGTCGTGATTGACAATGTGGCTAAT
GGCGATATTTCTGCCACTTCCACCGATGCGATTAACGGAAGTCAGTTGTATGCTGTGGCA
AAAGGGGTAACAAACCTTGCTGGACAAGTGAATAATCTTGAGGGCAAAGTGAATAAAGTG
GGCAAACGTGCAGATGCAGGTACAGCAAGTGCATTAGCGGCTTCACAGTTACCACAAGCC
ACTATGCCAGGTAAATCAATGGTTGCTATTGCGGGAAGTAGTTATCAAGGTCAAAATGGT
TTAGCTATCGGGGTATCAAGAATTTCCGATAATGGCAAAGTGATTATTCGCTTGTCAGGC
ACAACCAATAGTCAAGGTAAAACAGGCGTTGCAGCAGGTGTTGGTTACCAGTGGTAA

# Drug_Target_14_General_Function:
Secondary metabolites biosynthesis, transport and catabolism

# Drug_Target_14_General_References:
12410830	Laarmann S, Cutter D, Juehne T, Barenkamp SJ, St Geme JW: The Haemophilus influenzae Hia autotransporter harbours two adhesive pockets that reside in the passenger domain and recognize the same host cell receptor. Mol Microbiol. 2002 Nov;46(3):731-43.
8730864	Barenkamp SJ, St Geme JW 3rd: Identification of a second family of high-molecular-weight adhesion proteins expressed by non-typable Haemophilus influenzae. Mol Microbiol. 1996 Mar;19(6):1215-23.

# Drug_Target_14_HGNC_ID:
Not Available

# Drug_Target_14_HPRD_ID:
Not Available

# Drug_Target_14_ID:
6475

# Drug_Target_14_Locus:
Not Available

# Drug_Target_14_Molecular_Weight:
114014.5

# Drug_Target_14_Name:
Adhesin

# Drug_Target_14_Number_of_Residues:
1098

# Drug_Target_14_PDB_ID:
1S7M

# Drug_Target_14_Pathway:
Not Available

# Drug_Target_14_Pfam_Domain_Function:
PF03895	YadA
PF05662	HIM

# Drug_Target_14_Protein_Sequence:
>Adhesin
MNKIFNVIWNVVTQTWVVVSELTRTHTKCASATVAVAVLATLLSATVEANNNTPVTNKLK
AYGDANFNFTNNSIADAEKQVQEAYKGLLNLNEKNASDKLLVEDNTAATVGNLRKLGWVL
SSKNGTRNEKSQQVKHADEVLFEGKGGVQVTSTSENGKHTITFALAKDLGVKTATVSDTL
TIGGGAAAGATTTPKVNVTSTTDGLKFAKDAAGANGDTTVHLNGIGSTLTDTLVGSPATH
IDGGDQSTHYTRAASIKDVLNAGWNIKGVKAGSTTGQSENVDFVHTYDTVEFLSADTETT
TVTVDSKENGKRTEVKIGAKTSVIKEKDGKLFTGKANKETNKVDGANATEDADEGKGLVT
AKDVIDAVNKTGWRIKTTDANGQNGDFATVASGTNVTFASGNGTTATVTNGTDGITVKYD
AKVGDGLKLDGDKIAADTTALTVNDGKNANNPKGKVADVASTDEKKLVTAKGLVTALNSL
SWTTTAAEADGGTLDGNASEQEVKAGDKVTFKAGKNLKVKQEGANFTYSLQDALTGLTSI
TLGTGNNGAKTEINKDGLTITPANGAGANNANTISVTKDGISAGGQSVKNVVSGLKKFGD
ANFDPLTSSADNLTKQNDDAYKGLTNLDEKGTDKQTPVVADNTAATVGDLRGLGWVISAD
KTTGGSTEYHDQVRNANEVKFKSGNGINVSGKTVNGRREITFELAKGEVVKSNEFTVKET
NGKETSLVKVGDKYYSKEDIDLTTGQPKLKDGNTVAAKYQDKGGKVVSVTDNTEATITNK
GSGYVTGNQVADAIAKSGFELGLADEADAKAAFDDKTKALSAGTTEIVNAHDKVRFANGL
NTKVSAATVESTDANGDKVTTTFVKTDVELPLTQIYNTDANGKKITKVVKDGQTKWYELN
ADGTADMTKEVTLGNVDSDGKKVVKDNDGKWYHAKADGTADKTKGEVSNDKVSTDEKHVV
SLDPNDQSKGKGVVIDNVANGDISATSTDAINGSQLYAVAKGVTNLAGQVNNLEGKVNKV
GKRADAGTASALAASQLPQATMPGKSMVAIAGSSYQGQNGLAIGVSRISDNGKVIIRLSG
TTNSQGKTGVAAGVGYQW

# Drug_Target_14_Reaction:
Not Available

# Drug_Target_14_Signals:
None

# Drug_Target_14_Specific_Function:
Not Available

# Drug_Target_14_SwissProt_ID:
Q48152

# Drug_Target_14_SwissProt_Name:
Q48152_HAEIF

# Drug_Target_14_Synonyms:
SubName: Hia

# Drug_Target_14_Theoretical_pI:
6.35

# Drug_Target_14_Transmembrane_Regions:
None

# Drug_Target_15_Cellular_Location:
Cell outer membrane

# Drug_Target_15_Chromosome_Location:
Not Available

# Drug_Target_15_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_15_Essentiality:
Essential

# Drug_Target_15_GenAtlas_ID:
Not Available

# Drug_Target_15_GenBank_ID_Gene:
X53313

# Drug_Target_15_GenBank_ID_Protein:
45379

# Drug_Target_15_GeneCard_ID:
oprP

# Drug_Target_15_Gene_Name:
oprP

# Drug_Target_15_Gene_Sequence:
>1323 bp
ATGATTCGCAGACACTCGTGCAAAGGGGTGGGGAGCAGTGTTGCCTGGAGTTTGCTGGGC
CTGGCGATTTCCGCGCAGAGCCTGGCCGGGACCGTGACCACCGACGGTGCCGACATCGTG
ATCAAGACCAAGGGCGGCCTCGAAGTCGCCACCACCGACAAGGAATTCAGCTTCAAGCTC
GGCGGCCGCCTGCAGGCCGACTACGGCCGCTTCGACGGCTACTACACGAACAACGGCAAT
ACCGCCGATGCCGCCTACTTCCGCCGCGCCTACCTGGAGTTCGGCGGCACCGCCTACCGG
GACTGGAAGTACCAGATCAACTACGACCTGTCGCGCAACGTCGGCAACGACAGCGCCGGC
TACTTTGACGAAGCTTCGGTCACCTATACCGGCTTCAACCCGGTCAACCTGAAGTTCGGC
CGCTTCTACACCGACTTCGGCCTGGAAAAGGCCACCAGCTCCAAATGGGTCACCGCGCTG
GAGCGCAACCTCACCTACGACATCGCCGACTGGGTCAACGACAACGTCGGTACCGGTATC
CAAGCCAGCTCGGTGGTGGGCGGCATGGCTTTCCTCTCTGGCAGCGTGTTCAGCGAGAAC
AACAACGATACCGACGGCGACACGGTCAAGCGCTACAACCTGCGCGGCGTGTTCGCGCCG
CTGCACGAGCCGGGCAACGTGGTGCACCTGGGCCTGCAATACGCCTATCGCGACCTGGAG
GACAGCGCGGTGGATACCCGGATCCGCCCGCGCATGGGCATGCGCGGCGTCTCCACCAAT
GGCGGCAACGATGCCGGCAGCAATGGCAACCGCGGTCTGTTCGGCGGCAGTTCGGCAGTC
GAGGGGCTGTGGAAGGACGACTCGGTCTGGGGCCTGGAAGGCGCCTGGGCGCTGGGTGCC
TTCTCGGCCCAGGCCGAGTACCTGCGGCGCACGGTCAAGGCCGAGCGCGACCGCGAGGAT
CTCAAGGCCTCCGGCTATTACGCGCAACTGGCCTACACCCTCACCGGCGAGCCGCGCCTC
TACAAGCTGGACGGCGCCAAGTTCGACACCATCAAGCCGGAGAACAAGGAAATCGGCGCC
TGGGAGCTGTTCTACCGCTACGACTCGATCAAGGTCGAGGATGACAACATCGTCGTCGAC
AGCGCCACCCGCGAGGTCGGCGACGCCAAGGGCAAGACCCGTGCCCTGGGCGTCAACTGG
TACGCCAACGAGGCGGTGAAGGTTTCCGCCAACTACGTCAAGGCGAAGACCGACAAGATC
AGCAATGCCAACGGCGACGATAGCGGCGATGGCCTGGTGATGCGCCTGCAGTACGTGTTC
TGA

# Drug_Target_15_General_Function:
Inorganic ion transport and metabolism

# Drug_Target_15_General_References:
10984043	Stover CK, Pham XQ, Erwin AL, Mizoguchi SD, Warrener P, Hickey MJ, Brinkman FS, Hufnagle WO, Kowalik DJ, Lagrou M, Garber RL, Goltry L, Tolentino E, Westbrock-Wadman S, Yuan Y, Brody LL, Coulter SN, Folger KR, Kas A, Larbig K, Lim R, Smith K, Spencer D, Wong GK, Wu Z, Paulsen IT, Reizer J, Saier MH, Hancock RE, Lory S, Olson MV: Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature. 2000 Aug 31;406(6799):959-64.
1406271	Siehnel RJ, Egli C, Hancock RE: Polyphosphate-selective porin OprO of Pseudomonas aeruginosa: expression, purification and sequence. Mol Microbiol. 1992 Aug;6(16):2319-26.
1697017	Siehnel R, Martin NL, Hancock RE: Sequence and relatedness in other bacteria of the Pseudomonas aeruginosa oprP gene coding for the phosphate-specific porin P. Mol Microbiol. 1990 May;4(5):831-8.
2451538	Worobec EA, Martin NL, McCubbin WD, Kay CM, Brayer GD, Hancock RE: Large-scale purification and biochemical characterization of crystallization-grade porin protein P from Pseudomonas aeruginosa. Biochim Biophys Acta. 1988 Apr 7;939(2):366-74.
2456446	Siehnel RJ, Worobec EA, Hancock RE: Regulation of components of the Pseudomonas aeruginosa phosphate-starvation-inducible regulon in Escherichia coli. Mol Microbiol. 1988 May;2(3):347-52.
3017428	Hancock RE, Benz R: Demonstration and chemical modification of a specific phosphate binding site in the phosphate-starvation-inducible outer membrane porin protein P of Pseudomonas aeruginosa. Biochim Biophys Acta. 1986 Sep 11;860(3):699-707.

# Drug_Target_15_HGNC_ID:
Not Available

# Drug_Target_15_HPRD_ID:
Not Available

# Drug_Target_15_ID:
6476

# Drug_Target_15_Locus:
Not Available

# Drug_Target_15_Molecular_Weight:
48211.0

# Drug_Target_15_Name:
Porin P

# Drug_Target_15_Number_of_Residues:
440

# Drug_Target_15_PDB_ID:
Not Available

# Drug_Target_15_Pathway:
Not Available

# Drug_Target_15_Pfam_Domain_Function:
PF07396	Porin_O_P

# Drug_Target_15_Protein_Sequence:
>Porin P
MIRRHSCKGVGSSVAWSLLGLAISAQSLAGTVTTDGADIVIKTKGGLEVATTDKEFSFKL
GGRLQADYGRFDGYYTNNGNTADAAYFRRAYLEFGGTAYRDWKYQINYDLSRNVGNDSAG
YFDEASVTYTGFNPVNLKFGRFYTDFGLEKATSSKWVTALERNLTYDIADWVNDNVGTGI
QASSVVGGMAFLSGSVFSENNNDTDGDSVKRYNLRGVFAPLHEPGNVVHLGLQYAYRDLE
DSAVDTRIRPRMGMRGVSTNGGNDAGSNGNRGLFGGSSAVEGLWKDDSVWGLEGAWALGA
FSAQAEYLRRTVKAERDREDLKASGYYAQLAYTLTGEPRLYKLDGAKFDTIKPENKEIGA
WELFYRYDSIKVEDDNIVVDSATREVGDAKGKTHTLGVNWYANEAVKVSANYVKAKTDKI
SNANGDDSGDGLVMRLQYVF

# Drug_Target_15_Reaction:
Not Available

# Drug_Target_15_Signals:
1-29

# Drug_Target_15_Specific_Function:
Anion specific, the binding site has higher affinity for phosphate than chloride ions. Porin O has a higher affinity for polyphosphates (tripolyphosphate and pyrophosphate) while porin P has a higher affinity for orthophosphate

# Drug_Target_15_SwissProt_ID:
P05695

# Drug_Target_15_SwissProt_Name:
PORP_PSEAE

# Drug_Target_15_Synonyms:
Outer membrane protein D1

# Drug_Target_15_Theoretical_pI:
5.21

# Drug_Target_15_Transmembrane_Regions:
None

# Drug_Target_16_Cellular_Location:
Cell outer membrane

# Drug_Target_16_Chromosome_Location:
Not Available

# Drug_Target_16_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_16_Essentiality:
Essential

# Drug_Target_16_GenAtlas_ID:
Not Available

# Drug_Target_16_GenBank_ID_Gene:
X63152

# Drug_Target_16_GenBank_ID_Protein:
45371

# Drug_Target_16_GeneCard_ID:
oprD

# Drug_Target_16_Gene_Name:
oprD

# Drug_Target_16_Gene_Sequence:
>1332 bp
ATGAAAGTGATGAAGTGGAGCGCCATTGCACTGGCGGTTTCCGCAGGTAGCACTCAGTTC
GCCGTGGCCGACGCATTCGTCAGCGATCAGGCCGAAGCGAAGGGGTTCATCGAAGACAGC
AGCCTCGACCTGCTGCTCCGCAACTACTATTTCAACCGTGACGGCAAGAGCGGCAGCGGG
GACCGCGTCGACTGGACCCAAGGCTTCCTCACCACCTATGAATCCGGCTTCACCCAAGGC
ACTGTGGGCTTCGGCGTCGATGCCTTCGGCTACCTGGGCCTGAAGCTCGACGGCACCTCC
GACAAGACCGGCACCGGCAACCTGCCGGTGATGAACGACGGCAAGCCGCGCGATGACTAC
AGCCGCGCCGGCGGCGCCGTGAAGGTGCGCATCTCCAAGACCATGCTGAAGTGGGGCGAG
ATGCAACCGACCGCCCCGGTCTTCGCCGCTGGCGGCAGCCGCCTGTTCCCGCAGACCGCG
ACCGGCTTCCAGCTGCAGAGCAGCGAATTCGAAGGGCTCGACCTCGAGGCAGGCCACTTC
ACCGAGGGCAAGGAGCCGACCACCGTCAAATCGCGTGGCGAACTCTATGCCACCTACGCA
GGCGAGACCGCCAAGAGCGCCGATTTCATTGGGGGCCGCTACGCAATCACCGATAACCTC
AGCGCCTCCCTGTACGGCGCCGAACTCGAAGACATCTATCGCCAGTATTACCTGAACAGC
AACTACACCATCCCACTGGCATCCGACCAATCGCTGGGCTTCGATTTCAACATCTACCGC
ACAAACGATGAAGGCAAGGCCAAGGCCGGCGACATCAGCAACACCACTTGGTCCCTGGCG
GCAGCCTACACTCTGGATGCGCACACTTTCACCTTGGCCTACCAGAAGGTCCATGGCGAT
CAGCCGTTTGATTATATCGGCTTCGGCCGCAACGGCTCTGGCGCAGGTGGCGACTCGATT
TTCCTCGCCAACTCTGTCCAGTACTCCGACTTCAACGGCCCTGGCGAGAAATCCTGGCAG
GCTCGCTACGACCTGAACCTAGCCTCCTATGGCGTTCCCGGCCTGACTTTCATGGTCCGC
TATATCAATGGCAAGGACATCGATGGCACCAAGATGTCTGACAACAACGTCGGCTATAAG
AACTACGGCTACGGCGAGGATGGCAAGCACCACGAAACCAACCTCGAAGCCAAGTACGTG
GTCCAGTCCGGTCCGGCCAAGGACCTGTCGTTCCGCATCCGCCAGGCCTGGCACCGTGCC
AACGCCGACCAGGGCGAAGGCGACCAGAACGAGTTCCGCCTGATCGTCGACTATCCGCTG
TCGATCCTGTAA

# Drug_Target_16_General_Function:
Involved in porin activity

# Drug_Target_16_General_References:
10984043	Stover CK, Pham XQ, Erwin AL, Mizoguchi SD, Warrener P, Hickey MJ, Brinkman FS, Hufnagle WO, Kowalik DJ, Lagrou M, Garber RL, Goltry L, Tolentino E, Westbrock-Wadman S, Yuan Y, Brody LL, Coulter SN, Folger KR, Kas A, Larbig K, Lim R, Smith K, Spencer D, Wong GK, Wu Z, Paulsen IT, Reizer J, Saier MH, Hancock RE, Lory S, Olson MV: Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature. 2000 Aug 31;406(6799):959-64.
1339257	Yoneyama H, Yoshihara E, Nakae T: Nucleotide sequence of the protein D2 gene of Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1992 Aug;36(8):1791-3.
1427017	Huang H, Siehnel RJ, Bellido F, Rawling E, Hancock RE: Analysis of two gene regions involved in the expression of the imipenem-specific, outer membrane porin protein OprD of Pseudomonas aeruginosa. FEMS Microbiol Lett. 1992 Oct 15;76(3):267-73.
2118530	Trias J, Nikaido H: Protein D2 channel of the Pseudomonas aeruginosa outer membrane has a binding site for basic amino acids and peptides. J Biol Chem. 1990 Sep 15;265(26):15680-4.
8012497	Michea-Hamzehpour M, Sanchez JC, Epp SF, Paquet N, Hughes GJ, Hochstrasser D, Pechere JC: Two-dimensional polyacrylamide gel electrophoresis isolation and microsequencing of Pseudomonas aeruginosa proteins. Enzyme Protein. 1993;47(1):1-8.
8843159	Yoshihara E, Gotoh N, Nishino T, Nakae T: Protein D2 porin of the Pseudomonas aeruginosa outer membrane bears the protease activity. FEBS Lett. 1996 Sep 30;394(2):179-82.
9636669	Yoshihara E, Yoneyama H, Ono T, Nakae T: Identification of the catalytic triad of the protein D2 protease in Pseudomonas aeruginosa. Biochem Biophys Res Commun. 1998 Jun 9;247(1):142-5.

# Drug_Target_16_HGNC_ID:
Not Available

# Drug_Target_16_HPRD_ID:
Not Available

# Drug_Target_16_ID:
6477

# Drug_Target_16_Locus:
Not Available

# Drug_Target_16_Molecular_Weight:
48360.0

# Drug_Target_16_Name:
Porin D

# Drug_Target_16_Number_of_Residues:
443

# Drug_Target_16_PDB_ID:
Not Available

# Drug_Target_16_Pathway:
Not Available

# Drug_Target_16_Pfam_Domain_Function:
PF03573	OprD

# Drug_Target_16_Protein_Sequence:
>Porin D
MKVMKWSAIALAVSAGSTQFAVADAFVSDQAEAKGFIEDSSLDLLLRNYYFNRDGKSGSG
DRVDWTQGFLTTYESGFTQGTVGFGVDAFGYLGLKLDGTSDKTGTGNLPVMNDGKPRDDY
SRAGGAVKVRISKTMLKWGEMQPTAPVFAAGGSRLFPQTATGFQLQSSEFEGLDLEAGHF
TEGKEPTTVKSRGELYATYAGETAKSADFIGGRYAITDNLSASLYGAELEDIYRQYYLNS
NYTIPLASDQSLGFDFNIYRTNDEGKAKAGDISNTTWSLAAAYTLDAHTFTLAYQKVHGD
QPFDYIGFGRNGSGAGGDSIFLANSVQYSDFNGPGEKSWQARYDLNLASYGVPGLTFMVR
YINGKDIDGTKMSDNNVGYKNYGYGEDGKHHETNLEAKYVVQSGPAKDLSFRIRQAWHRA
NADQGEGDQNEFRLIVDYPLSIL

# Drug_Target_16_Reaction:
Not Available

# Drug_Target_16_Signals:
1-23

# Drug_Target_16_Specific_Function:
Porin with a specificity for basic amino acids. Also possesses serine protease activity

# Drug_Target_16_SwissProt_ID:
P32722

# Drug_Target_16_SwissProt_Name:
PORD_PSEAE

# Drug_Target_16_Synonyms:
Imipenem/basic amino acid-specific outer membrane pore
Outer membrane protein D2

# Drug_Target_16_Theoretical_pI:
4.75

# Drug_Target_16_Transmembrane_Regions:
None

# Drug_Target_17_Cellular_Location:
Cell outer membrane

# Drug_Target_17_Chromosome_Location:
Not Available

# Drug_Target_17_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_17_Essentiality:
Essential

# Drug_Target_17_GenAtlas_ID:
Not Available

# Drug_Target_17_GenBank_ID_Gene:
Not Available

# Drug_Target_17_GenBank_ID_Protein:
Not Available

# Drug_Target_17_GeneCard_ID:
Not Available

# Drug_Target_17_Gene_Name:
Not Available

# Drug_Target_17_Gene_Sequence:
Not Available

# Drug_Target_17_General_Function:
Involved in transporter activity

# Drug_Target_17_General_References:
1328651	Weiss MS, Schulz GE: Structure of porin refined at 1.8 A resolution. J Mol Biol. 1992 Sep 20;227(2):493-509.
1651239	Schiltz E, Kreusch A, Nestel U, Schulz GE: Primary structure of porin from Rhodobacter capsulatus. Eur J Biochem. 1991 Aug 1;199(3):587-94.
1707373	Weiss MS, Kreusch A, Schiltz E, Nestel U, Welte W, Weckesser J, Schulz GE: The structure of porin from Rhodobacter capsulatus at 1.8 A resolution. FEBS Lett. 1991 Mar 25;280(2):379-82.
2165921	Weiss MS, Wacker T, Weckesser J, Welte W, Schulz GE: The three-dimensional structure of porin from Rhodobacter capsulatus at 3 A resolution. FEBS Lett. 1990 Jul 16;267(2):268-72.

# Drug_Target_17_HGNC_ID:
Not Available

# Drug_Target_17_HPRD_ID:
Not Available

# Drug_Target_17_ID:
6478

# Drug_Target_17_Locus:
Not Available

# Drug_Target_17_Molecular_Weight:
31536.3

# Drug_Target_17_Name:
Porin

# Drug_Target_17_Number_of_Residues:
301

# Drug_Target_17_PDB_ID:
3POR

# Drug_Target_17_Pathway:
Not Available

# Drug_Target_17_Pfam_Domain_Function:
Not Available

# Drug_Target_17_Protein_Sequence:
>Porin
EVKLSGDARMGVMYNGDDWNFSSRSRVLFTMSGTTDSGLEFGASFKAHESVGAETGEDGT
VFLSGAFGKIEMGDALGASEALFGDLYEVGYTDLDDRGGNDIPYLTGDERLTAEDNPVLL
YTYSAGAFSVAASMSDGKVGETSEDDAQEMAVAAAYTFGNYTVGLGYEKIDSPDTALMAD
MEQLELAAIAKFGATNVKAYYADGELDRDFARAVFDLTPVAAAATAVDHKAYGLSVDSTF
GATTVGGYVQVLDIDTIDDVTYYGLGASYDLGGGASIVGGIADNDLPNSDMVADLGVKFK
F

# Drug_Target_17_Reaction:
Not Available

# Drug_Target_17_Signals:
None

# Drug_Target_17_Specific_Function:
Forms channels that allow the passive diffusion of small hydrophilic solutes up to an exclusion limit of about 0.6 kDa

# Drug_Target_17_SwissProt_ID:
P31243

# Drug_Target_17_SwissProt_Name:
PORI_RHOCA

# Drug_Target_17_Synonyms:
Not Available

# Drug_Target_17_Theoretical_pI:
3.75

# Drug_Target_17_Transmembrane_Regions:
None

# Drug_Target_18_Cellular_Location:
Not Available

# Drug_Target_18_Chromosome_Location:
Not Available

# Drug_Target_18_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_18_Essentiality:
Essential

# Drug_Target_18_GenAtlas_ID:
Not Available

# Drug_Target_18_GenBank_ID_Gene:
AE004091

# Drug_Target_18_GenBank_ID_Protein:
9945819

# Drug_Target_18_GeneCard_ID:
opdK

# Drug_Target_18_Gene_Name:
opdK

# Drug_Target_18_Gene_Sequence:
>1545 bp
GTGTCCGTGGAACTTTGGCAGCAGTGCGTGGATCTTCTCCGCGATGAGCTGCCGTCCCAA
CAATTCAACACCTGGATCCGTCCCTTGCAGGTCGAAGCCGAAGGCGACGAATTGCGTGTG
TATGCACCCAACCGTTTCGTCCTCGATTGGGTGAACGAGAAATACCTCGGTCGGCTTCTG
GAACTGCTCGGTGAACGCGGCGAGGGTCAGTTGCCCGCGCTTTCCTTATTAATAGGCAGC
AAGCGTAGCCGTACGCCGCGCGCCGCCATCGTCCCATCGCAGACCCACGTGGCTCCCCCG
CCTCCGGTTGCTCCGCCGCCGGCGCCAGTGCAGCCGGTATCGGCCGCGCCCGTGGTAGTG
CCACGTGAAGAGCTGCCGCCAGTGACGACGGCTCCCAGCGTGTCGAGCGATCCCTACGAG
CCGGAAGAACCCAGCATCGATCCGCTGGCCGCCGCCATGCCGGCTGGAGCAGCGCCTGCG
GTGCGCACCGAGCGCAACGTCCAGGTCGAAGGTGCGCTGAAGCACACCAGCTATCTCAAC
CGTACCTTCACCTTCGAGAACTTCGTCGAGGGCAAGTCCAACCAGTTGGCCCGCGCCGCC
GCCTGGCAGGTGGCGGACAACCTCAAGCACGGCTACAACCCGCTGTTCCTCTACGGTGGC
GTCGGTCTGGGCAAGACCCACCTGATGCATGCGGTGGGCAACCACCTGCTGAAGAAGAAC
CCGAACGCCAAGGTGGTCTACCTGCATTCGGAACGTTTCGTCGCGGACATGGTGAAGGCC
TTGCAGCTCAACGCCATCAACGAATTCAAGCGCTTCTACCGCTCGGTGGACGCACTGTTG
ATCGACGACATCCAGTTCTTCGCCCGTAAGGAGCGCTCCCAGGAGGAGTTCTTCCACACC
TTCAATGCCCTTCTCGAAGGCGGCCAGCAGGTGATCCTCACCAGCGACCGCTATCCGAAG
GAAATCGAAGGCCTGGAAGAGCGGCTGAAATCCCGCTTCGGCTGGGGCCTGACGGTGGCC
GTCGAGCCGCCGGAACTGGAAACCCGGGTGGCGATCCTGATGAAGAAGGCCGAGCAGGCG
AAGATCGAGCTGCCGCACGATGCGGCCTTCTTCATCGCCCAGCGCATCCGTTCCAACGTG
CGTGAACTGGAAGGTGCGCTGAAGCGGGTGATCGCCCACTCGCACTTCATGGGCCGGCCG
ATCACCATCGAGCTGATTCGCGAGTCGCTGAAGGACCTGTTGGCCCTTCAGGACAAGCTG
GTCAGCATCGACAACATCCAGCGCACCGTCGCCGAGTACTACAAGATCAAGATATCCGAT
CTGTTGTCCAAGCGGCGTTCGCGCTCGGTGGCGCGCCCGCGCCAGGTGGCCATGGCGCTC
TCCAAGGAGCTGACCAACCACAGCCTGCCGGAGATCGGCGTGGCCTTCGGCGGTCGGGAT
CACACCACGGTGTTGCACGCCTGTCGTAAGATCGCTCAACTTAGGGAATCCGACGCGGAT
ATCCGCGAGGACTACAAGAACCTGCTGCGTACCCTGACAACCTGA

# Drug_Target_18_General_Function:
Involved in porin activity

# Drug_Target_18_General_References:
10984043	Stover CK, Pham XQ, Erwin AL, Mizoguchi SD, Warrener P, Hickey MJ, Brinkman FS, Hufnagle WO, Kowalik DJ, Lagrou M, Garber RL, Goltry L, Tolentino E, Westbrock-Wadman S, Yuan Y, Brody LL, Coulter SN, Folger KR, Kas A, Larbig K, Lim R, Smith K, Spencer D, Wong GK, Wu Z, Paulsen IT, Reizer J, Saier MH, Hancock RE, Lory S, Olson MV: Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature. 2000 Aug 31;406(6799):959-64.

# Drug_Target_18_HGNC_ID:
Not Available

# Drug_Target_18_HPRD_ID:
Not Available

# Drug_Target_18_ID:
6479

# Drug_Target_18_Locus:
Not Available

# Drug_Target_18_Molecular_Weight:
45777.8

# Drug_Target_18_Name:
Vanillate porin OpdK

# Drug_Target_18_Number_of_Residues:
417

# Drug_Target_18_PDB_ID:
Not Available

# Drug_Target_18_Pathway:
Not Available

# Drug_Target_18_Pfam_Domain_Function:
PF03573	OprD

# Drug_Target_18_Protein_Sequence:
>Vanillate porin OpdK
MKIRRKTAVPRNAGAVLPMLACLAAQAAEGGFLEDAKTDLVLRNYYFNRDFRDHDAGKSL
VDEWAQGFILKFSSGYTPGTVGVGLDAIGLFGVKLNSGRGTSNSELLPLHDDGRAADNYG
RVGVAAKLRVSASELKIGEMLPDIPLLRYDDGRLLPQTFRGFAVVSRELPGLALQAGRFD
AVSLRNSADMQDLSAWSAPTQKSDGFNYAGAEYRFNRERTQLGLWHGQLEDVYRQSYANL
LHKQRVGDWTLGANLGLFVDRDDGAARAGEIDSHTVYGLFSAGIGLHTFYLGLQKVGGDS
GWQSVYGSSGRSMGNDMFNGNFTNADERSWQVRYDYDFVGLGWPGLIGMVRYGHGSNATT
KAGSGGKEWERDVELGYTVQSGPLARLNVRLNHASNRRSFNSDFDQTRLVVSYPLSW

# Drug_Target_18_Reaction:
Not Available

# Drug_Target_18_Signals:
None

# Drug_Target_18_Specific_Function:
Not Available

# Drug_Target_18_SwissProt_ID:
Q9HUR5

# Drug_Target_18_SwissProt_Name:
Q9HUR5_PSEAE

# Drug_Target_18_Synonyms:
Not Available

# Drug_Target_18_Theoretical_pI:
7.79

# Drug_Target_18_Transmembrane_Regions:
None

# Drug_Target_19_Cellular_Location:
Cell outer membrane

# Drug_Target_19_Chromosome_Location:
Not Available

# Drug_Target_19_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_19_Essentiality:
Essential

# Drug_Target_19_GenAtlas_ID:
Not Available

# Drug_Target_19_GenBank_ID_Gene:
Y00529

# Drug_Target_19_GenBank_ID_Protein:
747709

# Drug_Target_19_GeneCard_ID:
papC

# Drug_Target_19_Gene_Name:
papC

# Drug_Target_19_Gene_Sequence:
>2511 bp
ATGAAAGACAGAATACCTTTTGCAGTCAACAATATTACCTGTGTGATATTGTTGTCTCTG
TTTTGTAACGCAGCCAGTGCCGTTGAGTTTAATACAGATGTACTTGACGCAGCGGACAAG
AAAAATATTGACTTCACCCGTTTTTCAGAAGCCGGCTATGTTCTGCCGGGGCAATATCTT
CTGGATGTGATTGTTAACGGGCAAAGTATTTCTCCCGCATCGTTACAGATTTCATTTGTT
GAACCTGCGTTGTCAGGAGATAAGGCAGAAAAAAAATTGCCGCAGGCCTGTCTGACATCA
GATATGGTCAGACTGATGGGGTTAACAGCAGAATCTCTGGATAAAGTTGTTTACTGGCAT
GATGGTCAGTGTGCGGATTTTCATGGGTTGCCGGGAGTGGATATTCGTCCTGATACCGGA
GCGGGCGTATTACGCATCAATATGCCGCAGGCCTGGCTTGAGTATTCTGATGCCACCTGG
CTGCCTCCCTCACGCTGGGACGACGGCATTCCCGGACTGATGCTGGATTATAACCTCAAC
GGGACGGTTTCCCGTAATTATCAGGGAGGAGACTCTCATCAGTTCAGTTATAACGGGACT
GTGGGGGGGAATCTGGGGCCCTGGCGCCTGCGGGCTGACTATCAGGGAAGCCAGGAGCAG
AGCCGCTACAACGGGGAAAAAACGACAAACAGAAATTTCACATGGAGTCGCTTTTATCTG
TTCCGTGCCATTCCACGATGGCGGGCAAACCTGACGCTGGGCGAGAATAATATCAACTCA
GATATATTCCGGTCATGGAGTTATACGGGAGCCAGCCTGGAAAGCGATGACCGGATGCTG
CCGCCCAGACTGCGAGGCTATGCACCGCAGATTACCGGGATTGCGGAGACTAATGCCCGT
GTTGTGGTGTCGCAGCAGGGACGGGTGCTGTACGACTCGATGGTCCCCGCAGGGCCATTC
AGTATTCAGGACCTGGACAGTTCAGTTCGCGGACGTCTTGATGTTGAGGTTATTGAACAG
AACGGACGGAAGAAAACCTTTCAGGTCGATACGGCCTCGGTTCCTTATCTGACGCGTCCG
GGACAGGTCCGGTACAAACTTGTCTCCGGTCGTTCCCGTGGATACGGGCATGAGACCGAA
GGGCCTGTATTTGCGACCGGAGAGGCATCCTGGGGGCTCAGTAACCAGTGGTCGCTGTAT
GGCGGGGCTGTGCTTGCCGGTGATTATAATGCACTGGCAGCCGGTGCCGGCTGGGACCTG
GGTGTGCCGGGGACCCTTTCCGCTGATATCACGCAGTCAGTAGCCCGTATTGAGGGAGAG
AGAACGTTTCAGGGAAAATCCTGGCGTCTGAGCTACTCCAAACGGTTTGATAATGCGGAT
GCCGACATTACGTTCGCCGGGTATCGTTTCTCAGAGCGAAACTATATGACCATGGAGCAG
TACCTGAACGCCCGCTACCGTAATGATTACAGCAGTCGGGAAAAAGAGATGTATACCGTT
ACGCTGAATAAAAACGTGGCGGACTGGAACACCTCTTTTAACCTGCAGTCCGAAAACATT
AAAGTAGCGGTTGACGCTCACCGTATAATAGTCCGTTTTCCGTATGTCCCAGTATGTCTG
ACGGCTGTACTGCAGGGTGTGGCGGTTGGATTGTCAGCCTCAAGGTCTAAATATCTGGGG
CGTGATAACGATTCTGCTTACCTGCGTATATCCGTGCCGCTGGGGACGGGGACAGCGAGC
TACAGTGGCAGTATGAGTAATGACCGTTATGTGAATATGGCCGGCTACACTGACACGTTC
AATGACGGTCTGGACAGCTACAGCCTGAACGCCGGCCTTAACAGTGGCGGTGGACTGACA
TCGCAACGTCAGATTAATGCCTATTACAGTCATCGTAGTCCGCTGGCAAATTTGTCCGCG
AATATTGCATCCCTGCAGAAAGGATATACGTCTTTCGGCGTCAGTGCTTCCGGTGGGGCA
ACAATTACCGGAAAAGGTGCGGCGTTACATGCAGGGGGAATGTCCGGTGGAACACGTCTT
CTTGTTGACACGGATGGTGTGGGAGGTGTACCGGTTGATGGCGGGCAGGTGGTGACAAAT
CGCTGGGGAACGGGCGTGGTGACTGACATCAGCAGTTATTACCGGAATACAACCTCTGTT
GACCTGAAGCGCTTACCGGATGATGTGGAAGCAACCCGTTCTGTTGTGGAATCGGCGCTG
ACAGAAGGTGCCATTGGTTACCGGAAATTCAGCGTGCTTAAAGGGAAACGTCTGTTTGCA
ATACTGCGTCTTGCTGATGGCTCTCAGCCCCCGTTTGGTGCCAGTGTAACCAGTGAAAAA
GGCCGGGAACTGGGCATGGTGGCCGACGAAGGCCTTGCCTGGCTGAGTGGCGTGACGCCG
GGGGAAACCCTGTCGGTAAACTGGGATGGAAAAATACAGTGTCAGGTAAATGTACCGGAG
ACAGCAATATCTGACCAGCAGTTATTGCTTCCCTGTACGCCTCAGAAATAA

# Drug_Target_19_General_Function:
Cell motility

# Drug_Target_19_General_References:
12399496	Thanassi DG, Stathopoulos C, Dodson K, Geiger D, Hultgren SJ: Bacterial outer membrane ushers contain distinct targeting and assembly domains for pilus biogenesis. J Bacteriol. 2002 Nov;184(22):6260-9.
1357526	Marklund BI, Tennent JM, Garcia E, Hamers A, Baga M, Lindberg F, Gaastra W, Normark S: Horizontal gene transfer of the Escherichia coli pap and prs pili operons as a mechanism for the development of tissue-specific adhesive properties. Mol Microbiol. 1992 Aug;6(16):2225-42.
2572580	Lindberg F, Tennent JM, Hultgren SJ, Lund B, Normark S: PapD, a periplasmic transport protein in P-pilus biogenesis. J Bacteriol. 1989 Nov;171(11):6052-8.
2897064	Norgren M, Baga M, Tennent JM, Normark S: Nucleotide sequence, regulation and functional analysis of the papC gene required for cell surface localization of Pap pili of uropathogenic Escherichia coli. Mol Microbiol. 1987 Sep;1(2):169-78.
7909802	Jacob-Dubuisson F, Striker R, Hultgren SJ: Chaperone-assisted self-assembly of pili independent of cellular energy. J Biol Chem. 1994 Apr 29;269(17):12447-55.
9501230	Thanassi DG, Saulino ET, Lombardo MJ, Roth R, Heuser J, Hultgren SJ: The PapC usher forms an oligomeric channel: implications for pilus biogenesis across the outer membrane. Proc Natl Acad Sci U S A. 1998 Mar 17;95(6):3146-51.

# Drug_Target_19_HGNC_ID:
Not Available

# Drug_Target_19_HPRD_ID:
Not Available

# Drug_Target_19_ID:
6480

# Drug_Target_19_Locus:
Not Available

# Drug_Target_19_Molecular_Weight:
91508.3

# Drug_Target_19_Name:
Outer membrane usher protein papC

# Drug_Target_19_Number_of_Residues:
836

# Drug_Target_19_PDB_ID:
Not Available

# Drug_Target_19_Pathway:
Not Available

# Drug_Target_19_Pfam_Domain_Function:
PF00577	Usher

# Drug_Target_19_Protein_Sequence:
>Outer membrane usher protein papC
MKDRIPFAVNNITCVILLSLFCNAASAVEFNTDVLDAADKKNIDFTRFSEAGYVLPGQYL
LDVIVNGQSISPASLQISFVEPALSGDKAEKKLPQACLTSDMVRLMGLTAESLDKVVYWH
DGQCADFHGLPGVDIRPDTGAGVLRINMPQAWLEYSDATWLPPSRWDDGIPGLMLDYNLN
GTVSRNYQGGDSHQFSYNGTVGGNLGPWRLRADYQGSQEQSRYNGEKTTNRNFTWSRFYL
FRAIPRWRANLTLGENNINSDIFRSWSYTGASLESDDRMLPPRLRGYAPQITGIAETNAR
VVVSQQGRVLYDSMVPAGPFSIQDLDSSVRGRLDVEVIEQNGRKKTFQVDTASVPYLTRP
GQVRYKLVSGRSRGYGHETEGPVFATGEASWGLSNQWSLYGGAVLAGDYNALAAGAGWDL
GVPGTLSADITQSVARIEGERTFQGKSWRLSYSKRFDNADADITFAGYRFSERNYMTMEQ
YLNARYRNDYSSREKEMYTVTLNKNVADWNTSFNLQYSRQTYWDIRKTDYYTVSVNRYFN
VFGLQGVAVGLSASRSKYLGRDNDSAYLRISVPLGTGTASYSGSMSNDRYVNMAGYTDTF
NDGLDSYSLNAGLNSGGGLTSQRQINAYYSHRSPLANLSANIASLQKGYTSFGVSASGGA
TITGKGAALHAGGMSGGTRLLVDTDGVGGVPVDGGQVVTNRWGTGVVTDISSYYRNTTSV
DLKRLPDDVEATRSVVESALTEGAIGYRKFSVLKGKRLFAILRLADGSQPPFGASVTSEK
GRELGMVADEGLAWLSGVTPGETLSVNWDGKIQCQVNVPETAISDQQLLLPCTPQK

# Drug_Target_19_Reaction:
Not Available

# Drug_Target_19_Signals:
1-24

# Drug_Target_19_Specific_Function:
Involved in the export and assembly of pili subunits across the outer membrane. Forms a hexameric ring-shaped pore in the outer bacterial membrane. The 2 nanometer-diameter pore allows the passage of the thin tip fibrillum. As for the rod, it probably unwinds into linear fibers which would therefore be narrow enough to pass through the pore

# Drug_Target_19_SwissProt_ID:
P07110

# Drug_Target_19_SwissProt_Name:
PAPC_ECOLX

# Drug_Target_19_Synonyms:
Not Available

# Drug_Target_19_Theoretical_pI:
6.54

# Drug_Target_19_Transmembrane_Regions:
None

# Drug_Target_1_Cellular_Location:
Cell outer membrane
multi-pass membrane protein

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
L37088

# Drug_Target_1_GenBank_ID_Protein:
559694

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
ompX

# Drug_Target_1_Gene_Sequence:
>516 bp
ATGAAAAAAATTGCATGTCTTTCAGCACTGGCCGCAGTTCTGGCTTTCACCGCAGGTACT
TCCGTAGCTGCGACTTCTACTGTAACTGGCGGTTACGCACAGAGCGACGCTCAGGGCCAA
ATGAACAAAATGGGCGGTTTCAACCTGAAATACCGCTATGAAGAAGACAACAGCCCGCTG
GGTGTGATCGGTTCTTTCACTTACACCGAGAAAAGCCGTACTGCAAGCTCTGGTGACTAC
AACAAAAACCAGTACTACGGCATCACTGCTGGTCCGGCTTACCGCATTAACGACTGGGCA
AGCATCTACGGTGTAGTGGGTGTGGGTTATGGTAAATTCCAGACCACTGAATACCCGACC
TACAAACACGACACCAGCGACTACGGTTTCTCCTACGGTGCGGGTCTGCAGTTCAACCCG
ATGGAAAACGTTGCTCTGGACTTCTCTTACGAGCAGAGCCGTATTCGTAGCGTTGACGTA
GGCACCTGGATTGCCGGTGTTGGTTACCGCTTCTAA

# Drug_Target_1_General_Function:
Not Available

# Drug_Target_1_General_References:
10545325	Vogt J, Schulz GE: The structure of the outer membrane protein OmpX from Escherichia coli reveals possible mechanisms of virulence. Structure. 1999 Oct 15;7(10):1301-9.
7836315	Mecsas J, Welch R, Erickson JW, Gross CA: Identification and characterization of an outer membrane protein, OmpX, in Escherichia coli that is homologous to a family of outer membrane proteins including Ail of Yersinia enterocolitica. J Bacteriol. 1995 Feb;177(3):799-804.
8021175	Lomovskaya OL, Kidwell JP, Matin A: Characterization of the sigma 38-dependent expression of a core Escherichia coli starvation gene, pexB. J Bacteriol. 1994 Jul;176(13):3928-35.
8905232	Oshima T, Aiba H, Baba T, Fujita K, Hayashi K, Honjo A, Ikemoto K, Inada T, Itoh T, Kajihara M, Kanai K, Kashimoto K, Kimura S, Kitagawa M, Makino K, Masuda S, Miki T, Mizobuchi K, Mori H, Motomura K, Nakamura Y, Nashimoto H, Nishio Y, Saito N, Horiuchi T, et al.: A 718-kb DNA sequence of the Escherichia coli K-12 genome corresponding to the 12.7-28.0 min region on the linkage map. DNA Res. 1996 Jun 30;3(3):137-55.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.
9629924	Molloy MP, Herbert BR, Walsh BJ, Tyler MI, Traini M, Sanchez JC, Hochstrasser DF, Williams KL, Gooley AA: Extraction of membrane proteins by differential solubilization for separation using two-dimensional gel electrophoresis. Electrophoresis. 1998 May;19(5):837-44.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
3720

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
18603

# Drug_Target_1_Name:
Outer membrane protein X precursor

# Drug_Target_1_Number_of_Residues:
171

# Drug_Target_1_PDB_ID:
1Q9F

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF06316	Ail_Lom

# Drug_Target_1_Protein_Sequence:
>Outer membrane protein X precursor
MKKIACLSALAAVLAFTAGTSVAATSTVTGGYAQSDAQGQMNKMGGFNLKYRYEEDNSPL
GVIGSFTYTEKSRTASSGDYNKNQYYGITAGPAYRINDWASIYGVVGVGYGKFQTTEYPT
YKHDTSDYGFSYGAGLQFNPMENVALDFSYEQSRIRSVDVGTWIAGVGYRF

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
1-23

# Drug_Target_1_Specific_Function:
Not Available

# Drug_Target_1_SwissProt_ID:
P0A917

# Drug_Target_1_SwissProt_Name:
OMPX_ECOLI

# Drug_Target_1_Synonyms:
Not Available

# Drug_Target_1_Theoretical_pI:
7.32

# Drug_Target_1_Transmembrane_Regions:
26-35
45-54
60-69
86-95
100-109
130-139
144-153
161-170

# Drug_Target_20_Cellular_Location:
Cell outer membrane

# Drug_Target_20_Chromosome_Location:
Not Available

# Drug_Target_20_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_20_Essentiality:
Essential

# Drug_Target_20_GenAtlas_ID:
Not Available

# Drug_Target_20_GenBank_ID_Gene:
EU372012

# Drug_Target_20_GenBank_ID_Protein:
166079762

# Drug_Target_20_GeneCard_ID:
ompC

# Drug_Target_20_Gene_Name:
ompC

# Drug_Target_20_Gene_Sequence:
Not Available

# Drug_Target_20_General_Function:
Cell wall/membrane/envelope biogenesis

# Drug_Target_20_General_References:
18292097	Liu YF, Yan JJ, Ko WC, Tsai SH, Wu JJ: Characterization of carbapenem-non-susceptible Escherichia coli isolates from a university hospital in Taiwan. J Antimicrob Chemother. 2008 May;61(5):1020-3. Epub 2008 Feb 20.

# Drug_Target_20_HGNC_ID:
Not Available

# Drug_Target_20_HPRD_ID:
Not Available

# Drug_Target_20_ID:
6443

# Drug_Target_20_Locus:
Not Available

# Drug_Target_20_Molecular_Weight:
40311.9

# Drug_Target_20_Name:
Outer membrane porin C

# Drug_Target_20_Number_of_Residues:
364

# Drug_Target_20_PDB_ID:
Not Available

# Drug_Target_20_Pathway:
Not Available

# Drug_Target_20_Pfam_Domain_Function:
PF00267	Porin_1

# Drug_Target_20_Protein_Sequence:
>Outer membrane porin C
MKVKVLSLLVPALLVAGAANAAEIYNKDGNKLDLYGKVDGLHYFSDNDSKDGDKTYMRLG
FKGETQVTDQLTGYGQWEYQIQGNEPESDNSSWTRVAFAGLKFQDVGSFDYGRNYGVVYD
VTSWTDVLPEFGGDTYDSDNFMQQRGNGFATYRNTDFFGLVDGLDFAVQYQGKNGSAHGE
GMTTNGRDDVFEQNGDGVGGSITYNYEGFGIGAAVSSSKRTWDQNNTGLIGTGDRAETYT
GGLKYDANNIYLAAQYTQTYNATRVGSLGWANKAQNFEAVAQYQFDFGLRPSLAYLQSKG
KNLGRGYDDEDILKYVDVGATYYFNKNMSTYVDYKINLLDDNRFTRDAGINTDDIVALGL
VYQF

# Drug_Target_20_Reaction:
Not Available

# Drug_Target_20_Signals:
1-21

# Drug_Target_20_Specific_Function:
Not Available

# Drug_Target_20_SwissProt_ID:
Q9K597

# Drug_Target_20_SwissProt_Name:
Q9K597_ECOLX

# Drug_Target_20_Synonyms:
SubName: Outer membrane protein C

# Drug_Target_20_Theoretical_pI:
4.30

# Drug_Target_20_Transmembrane_Regions:
None

# Drug_Target_21_Cellular_Location:
Not Available

# Drug_Target_21_Chromosome_Location:
Not Available

# Drug_Target_21_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_21_Essentiality:
Essential

# Drug_Target_21_GenAtlas_ID:
Not Available

# Drug_Target_21_GenBank_ID_Gene:
AF100782

# Drug_Target_21_GenBank_ID_Protein:
6066149

# Drug_Target_21_GeneCard_ID:
tbuX

# Drug_Target_21_Gene_Name:
tbuX

# Drug_Target_21_Gene_Sequence:
Not Available

# Drug_Target_21_General_Function:
Lipid transport and metabolism

# Drug_Target_21_General_References:
10671442	Kahng HY, Byrne AM, Olsen RH, Kukor JJ: Characterization and role of tbuX in utilization of toluene by Ralstonia pickettii PKO1. J Bacteriol. 2000 Mar;182(5):1232-42.

# Drug_Target_21_HGNC_ID:
Not Available

# Drug_Target_21_HPRD_ID:
Not Available

# Drug_Target_21_ID:
6481

# Drug_Target_21_Locus:
Not Available

# Drug_Target_21_Molecular_Weight:
47861.7

# Drug_Target_21_Name:
TbuX

# Drug_Target_21_Number_of_Residues:
458

# Drug_Target_21_PDB_ID:
Not Available

# Drug_Target_21_Pathway:
Not Available

# Drug_Target_21_Pfam_Domain_Function:
PF03349	Toluene_X

# Drug_Target_21_Protein_Sequence:
>TbuX
MKGNYVRAATAICVAICGTHARATDVFNLEGFGPVSRAMGGTGAAFDIGPAAMMENPATL
GLMGEGRHFSLGLDVVSTDIKVTNTATGETASSGNHGNNNGPYFAPQTAFVYRQGRYAFG
AGIFAEGGLGTQYGGSSFLSRTSNGVDTGLDQFSRLLVLRVPFSAAYHVTDKLTVGASVD
AVWTSLNLGTLLDVSQIGTLAGQGRVSGTLVPTLLGVPGLSGGYIDFSRNAPVGGGVQAW
GIGGRLGLTYQVTPDTRIGAAYQAKTHVGDLTGQATLSAVSSVAGNIPLKGDVTVRNFQM
PAQLTVGISHQFNDQLSVSADYQRVFWSSVMKDMNVGFVQSGSAANLDLSLPQNYRDISV
FGIGAEYRYNAKWTFRGGFHYAQEAIPGNMLLAVVPATPTTSLTGGVSYAIGKNDVIDFA
LSVALRKTLDNASQPNTAVPISVTHSQVNAVIAYQKRF

# Drug_Target_21_Reaction:
Not Available

# Drug_Target_21_Signals:
None

# Drug_Target_21_Specific_Function:
Not Available

# Drug_Target_21_SwissProt_ID:
Q9RBW8

# Drug_Target_21_SwissProt_Name:
Q9RBW8_BURPI

# Drug_Target_21_Synonyms:
Not Available

# Drug_Target_21_Theoretical_pI:
8.56

# Drug_Target_21_Transmembrane_Regions:
None

# Drug_Target_22_Cellular_Location:
Not Available

# Drug_Target_22_Chromosome_Location:
Not Available

# Drug_Target_22_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_22_Essentiality:
Essential

# Drug_Target_22_GenAtlas_ID:
Not Available

# Drug_Target_22_GenBank_ID_Gene:
CP000712

# Drug_Target_22_GenBank_ID_Protein:
148509318

# Drug_Target_22_GeneCard_ID:
Not Available

# Drug_Target_22_Gene_Name:
Pput_2883

# Drug_Target_22_Gene_Sequence:
>1518 bp
GTGTCAGTGGAACTTTGGCAGCAGTGCGTGGAGCTTCTGCGCGATGAACTGCCTGCCCAG
CAATTCAACACCTGGATCCGTCCGCTACAGGTCGAAGCCGAAGGCGACGAGTTGCGCGTC
TATGCGCCTAACCGTTTCGTTCTCGATTGGGTCAATGAAAAGTACCTGGGTCGTTTGCTC
GAGCTGTTGGGTGAGAACGGTAGCGGCATTGCACCAGCCCTTTCCTTATTAATAGGTAGC
CGCCGCAGCTCGGCCCCAAGGGCTGCACCCAACGCGCCGGTCAGCGCTGCCGTTGCGGCT
TCGCTGGCGCAGACTCAGGCGCACAAGACGGCCCCGGCAGCAGCGGTTGAACCCGTTGCC
GTGGCCGCGGCCGAGCCTGTATTGGTCGAGACGTCTTCGCGTGACAGCTTTGATGCCATG
GCCGAGCCTGCTGCTGCGCCGCCCAGTGGTGGCCGGGCTGAACAGCGCACCGTGCAGGTT
GAAGGTGCGCTCAAGCACACCAGTTACCTGAACCGGACCTTTACCTTTGACACCTTCGTC
GAAGGTAAGTCGAACCAGCTCGCCCGCGCGGCTGCCTGGCAGGTTGCGGACAACCCTAAG
CATGGCTACAACCCACTGTTCCTTTATGGCGGTGTGGGTTTGGGTAAAACCCACCTTATG
CATGCTGTGGGTAACCATCTGCTGAAGAAGAATCCGAACGCCAAGGTGGTGTACCTGCAT
TCGGAGCGCTTCGTCGCGGACATGGTCAAAGCGTTGCAACTCAACGCCATCAACGAATTC
AAGCGCTTCTACCGCTCGGTGGACGCGTTGCTGATCGACGATATCCAGTTCTTCGCTCGC
AAAGAGCGCTCGCAAGAAGAGTTTTTCCACACCTTCAACGCCTTGCTTGAGGGTGGCCAG
CAGGTAATCCTTACCTCTGACCGCTATCCCAAGGAAATCGAAGGCCTGGAAGAGCGTCTG
AAGTCGCGCTTTGGTTGGGGCCTGACGGTGGCTGTCGAGCCGCCAGAGCTGGAGACCCGC
GTAGCGATCCTGATGAAGAAGGCCGACCAGGCCAAAGTCGAGCTCCCGCATGACGCAGCC
TTTTTCATCGCTCAGCGCATCCGGTCCAACGTCCGTGAGCTGGAAGGTGCACTGAAGCGA
GTTATTGCTCACTCGCACTTCATGGGGCGTGACATCACCATCGAGCTGATTCGTGAATCG
CTCAAGGATCTGTTGGCGCTGCAAGACAAACTGGTCAGTGTGGATAACATTCAGCGTACC
GTCGCTGAGTACTACAAGATCAAGATCTCCGATCTGTTGTCCAAGCGTCGTTCGCGTTCT
GTCGCGCGCCCGCGTCAGGTAGCCATGGCCCTGTCCAAGGAGTTGACCAACCACAGTCTG
CCGGAAATCGGCGACATGTTCGGTGGTCGCGACCATACGACCGTGCTGCACGCCTGCCGC
AAAATCAATGAACTGAAGGAATCCGACGCGGACATCCGCGAGGACTACAAGAACCTGCTG
CGGACGCTGACGACCTGA

# Drug_Target_22_General_Function:
Lipid transport and metabolism

# Drug_Target_22_General_References:
Not Available

# Drug_Target_22_HGNC_ID:
Not Available

# Drug_Target_22_HPRD_ID:
Not Available

# Drug_Target_22_ID:
6482

# Drug_Target_22_Locus:
Not Available

# Drug_Target_22_Molecular_Weight:
48224.7

# Drug_Target_22_Name:
Membrane protein involved in aromatic hydrocarbon degradation

# Drug_Target_22_Number_of_Residues:
453

# Drug_Target_22_PDB_ID:
Not Available

# Drug_Target_22_Pathway:
Not Available

# Drug_Target_22_Pfam_Domain_Function:
PF03349	Toluene_X

# Drug_Target_22_Protein_Sequence:
>Membrane protein involved in aromatic hydrocarbon degradation
MKIASVLALPLSGYAFSVHATQVFDLEGYGAISRAMGGTSSSYYTGNAALISNPATLSFA
PDGNQFELGLDVVTTDIKVHDSHGAEAKSSTRSNNRGPYVGPQLSYVAQLDDWRFGAGLF
VSSGLGTEYGSKSFLSQTENGIQTSFDNSSRLIVLRAPIGFSYQATSKLTFGASVDLVWT
SLNLELLLPSSQVGALTAQGNLSGGLVPSLAGFVGTGGAAHFSLSRNSTAGGAVDAVGWG
GRLGLTYKLTDNTVLGAMYNFKTSVGDLEGKATLSAISGDGAVLPLDGDIRVKNFEMPAS
LTLGLAHQFNERWVVAADIKRAYWGDVMDSMNVAFISQLGGIDVALPHRYQDITVASIGT
AYKYNNDLTLRAGYSYAQQALDSELILPVIPAYLKRHVTFGGEYDFDKDSRINLAISFGL
RERVQTPSYLAGTEMLRQSHSQINAVVSYSKNF

# Drug_Target_22_Reaction:
Not Available

# Drug_Target_22_Signals:
1-21

# Drug_Target_22_Specific_Function:
Not Available

# Drug_Target_22_SwissProt_ID:
A5W4F4

# Drug_Target_22_SwissProt_Name:
A5W4F4_PSEP1

# Drug_Target_22_Synonyms:
Not Available

# Drug_Target_22_Theoretical_pI:
6.10

# Drug_Target_22_Transmembrane_Regions:
None

# Drug_Target_23_Cellular_Location:
Not Available

# Drug_Target_23_Chromosome_Location:
Not Available

# Drug_Target_23_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_23_Essentiality:
Essential

# Drug_Target_23_GenAtlas_ID:
Not Available

# Drug_Target_23_GenBank_ID_Gene:
AE004091

# Drug_Target_23_GenBank_ID_Protein:
9945819

# Drug_Target_23_GeneCard_ID:
Not Available

# Drug_Target_23_Gene_Name:
PA4589

# Drug_Target_23_Gene_Sequence:
>1545 bp
GTGTCCGTGGAACTTTGGCAGCAGTGCGTGGATCTTCTCCGCGATGAGCTGCCGTCCCAA
CAATTCAACACCTGGATCCGTCCCTTGCAGGTCGAAGCCGAAGGCGACGAATTGCGTGTG
TATGCACCCAACCGTTTCGTCCTCGATTGGGTGAACGAGAAATACCTCGGTCGGCTTCTG
GAACTGCTCGGTGAACGCGGCGAGGGTCAGTTGCCCGCGCTTTCCTTATTAATAGGCAGC
AAGCGTAGCCGTACGCCGCGCGCCGCCATCGTCCCATCGCAGACCCACGTGGCTCCCCCG
CCTCCGGTTGCTCCGCCGCCGGCGCCAGTGCAGCCGGTATCGGCCGCGCCCGTGGTAGTG
CCACGTGAAGAGCTGCCGCCAGTGACGACGGCTCCCAGCGTGTCGAGCGATCCCTACGAG
CCGGAAGAACCCAGCATCGATCCGCTGGCCGCCGCCATGCCGGCTGGAGCAGCGCCTGCG
GTGCGCACCGAGCGCAACGTCCAGGTCGAAGGTGCGCTGAAGCACACCAGCTATCTCAAC
CGTACCTTCACCTTCGAGAACTTCGTCGAGGGCAAGTCCAACCAGTTGGCCCGCGCCGCC
GCCTGGCAGGTGGCGGACAACCTCAAGCACGGCTACAACCCGCTGTTCCTCTACGGTGGC
GTCGGTCTGGGCAAGACCCACCTGATGCATGCGGTGGGCAACCACCTGCTGAAGAAGAAC
CCGAACGCCAAGGTGGTCTACCTGCATTCGGAACGTTTCGTCGCGGACATGGTGAAGGCC
TTGCAGCTCAACGCCATCAACGAATTCAAGCGCTTCTACCGCTCGGTGGACGCACTGTTG
ATCGACGACATCCAGTTCTTCGCCCGTAAGGAGCGCTCCCAGGAGGAGTTCTTCCACACC
TTCAATGCCCTTCTCGAAGGCGGCCAGCAGGTGATCCTCACCAGCGACCGCTATCCGAAG
GAAATCGAAGGCCTGGAAGAGCGGCTGAAATCCCGCTTCGGCTGGGGCCTGACGGTGGCC
GTCGAGCCGCCGGAACTGGAAACCCGGGTGGCGATCCTGATGAAGAAGGCCGAGCAGGCG
AAGATCGAGCTGCCGCACGATGCGGCCTTCTTCATCGCCCAGCGCATCCGTTCCAACGTG
CGTGAACTGGAAGGTGCGCTGAAGCGGGTGATCGCCCACTCGCACTTCATGGGCCGGCCG
ATCACCATCGAGCTGATTCGCGAGTCGCTGAAGGACCTGTTGGCCCTTCAGGACAAGCTG
GTCAGCATCGACAACATCCAGCGCACCGTCGCCGAGTACTACAAGATCAAGATATCCGAT
CTGTTGTCCAAGCGGCGTTCGCGCTCGGTGGCGCGCCCGCGCCAGGTGGCCATGGCGCTC
TCCAAGGAGCTGACCAACCACAGCCTGCCGGAGATCGGCGTGGCCTTCGGCGGTCGGGAT
CACACCACGGTGTTGCACGCCTGTCGTAAGATCGCTCAACTTAGGGAATCCGACGCGGAT
ATCCGCGAGGACTACAAGAACCTGCTGCGTACCCTGACAACCTGA

# Drug_Target_23_General_Function:
Lipid transport and metabolism

# Drug_Target_23_General_References:
10984043	Stover CK, Pham XQ, Erwin AL, Mizoguchi SD, Warrener P, Hickey MJ, Brinkman FS, Hufnagle WO, Kowalik DJ, Lagrou M, Garber RL, Goltry L, Tolentino E, Westbrock-Wadman S, Yuan Y, Brody LL, Coulter SN, Folger KR, Kas A, Larbig K, Lim R, Smith K, Spencer D, Wong GK, Wu Z, Paulsen IT, Reizer J, Saier MH, Hancock RE, Lory S, Olson MV: Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature. 2000 Aug 31;406(6799):959-64.

# Drug_Target_23_HGNC_ID:
Not Available

# Drug_Target_23_HPRD_ID:
Not Available

# Drug_Target_23_ID:
6483

# Drug_Target_23_Locus:
Not Available

# Drug_Target_23_Molecular_Weight:
49723.2

# Drug_Target_23_Name:
Probable outer membrane protein

# Drug_Target_23_Number_of_Residues:
463

# Drug_Target_23_PDB_ID:
Not Available

# Drug_Target_23_Pathway:
Not Available

# Drug_Target_23_Pfam_Domain_Function:
PF03349	Toluene_X

# Drug_Target_23_Protein_Sequence:
>Probable outer membrane protein
MPLLCALIVGGLFGTSQAQAGGFMVPTTNTAGWGRAMAGGSLFPNDPSAAFNNPAAMAFI
DKRIAQLTVNYADIDIKYNGDAYDYQGNPMTGGYQDGPGTPELGTNDGGQAGFGAWLPTG
FLVVPINDRFAFGLSQVVPMGMRSTWDPNWKGRDFAVDTKIETIGLTGSLSFKVNDNFSL
GAGVIIQRTSGFVSQNLDLYASAANSPGMGGIPFPASNSSALMRVKVDNTSPGFFAGAVW
KPTDRDTLGFAYHAKIRNKLKGHYNLYDHDGGLTEGAIEGGTPGLAYPGLDLRMGASASA
RLDIPAYASLDWVHQFNDRLSLGASATWTEWSSFQDLTLKSHGNTIVSIPYTYRNTWTLA
VGGDYKVTDQWTMRAGVAYDQTPTHNATRDPRIPDGDRYFASLGAGYRFQSMPELSIDAA
YSRQFVKEVPLKTVNQDRLGGGRLDGRATSKGQVFSLSATYDF

# Drug_Target_23_Reaction:
Not Available

# Drug_Target_23_Signals:
None

# Drug_Target_23_Specific_Function:
Not Available

# Drug_Target_23_SwissProt_ID:
Q9HVJ6

# Drug_Target_23_SwissProt_Name:
Q9HVJ6_PSEAE

# Drug_Target_23_Synonyms:
Not Available

# Drug_Target_23_Theoretical_pI:
6.26

# Drug_Target_23_Transmembrane_Regions:
None

# Drug_Target_24_Cellular_Location:
Not Available

# Drug_Target_24_Chromosome_Location:
Not Available

# Drug_Target_24_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_24_Essentiality:
Essential

# Drug_Target_24_GenAtlas_ID:
Not Available

# Drug_Target_24_GenBank_ID_Gene:
AE017221

# Drug_Target_24_GenBank_ID_Protein:
46195931

# Drug_Target_24_GeneCard_ID:
Not Available

# Drug_Target_24_Gene_Name:
TT_C0834

# Drug_Target_24_Gene_Sequence:
>771 bp
ATGGGCCTTTTCGCTGGCAAAGGGGTGCTGGTGACCGGAGGGGCCCGGGGTATCGGCCGG
GCCATCGCCCAGGCCTTCGCCCGGGAGGGGGCCTTGGTGGCCCTGTGCGACCTCCGCCCG
GAGGGGAAGGAGGTGGCGGAGGCCATCGGGGGGGCGTTTTTCCAGGTGGACCTCGAGGAC
GAGAGGGAGCGAGTGCGCTTCGTGGAGGAGGCCGCCTACGCCCTGGGCCGGGTGGACGTT
CTGGTCAACAACGCCGCCATCGCCGCCCCCGGCTCGGCCCTCACGGTGCGGCTTCCCGAG
TGGCGCAGGGTGCTTGAGGTCAACCTCACCGCCCCCATGCACCTTTCCGCCTTGGCCGCG
CGGGAGATGCGGAAGGTGGGCGGTGGGGCCATCGTCAACGTGGCCAGCGTGCAGGGGCTT
TTCGCCGAGCAGGAGAACGCCGCCTACAACGCTTCCAAGGGGGGGCTTGTGAACCTCACC
CGCTCCCTGGCGCTGGACCTCGCCCCCCTCCGCATCCGGGTGAACGCGGTAGCGCCCGGG
GCCATCGCCACGGAGGCGGTCCTGGAGGCCATCGCCCTCTCCCCGGACCCGGAGAGAACC
CGGAGGGACTGGGAGGACCTCCACGCCCTGAGGCGCCTGGGGAAGCCCGAGGAGGTGGCG
GAGGCCGTCCTCTTCCTGGCCTCGGAGAAGGCTAGCTTCATCACCGGGGCCATCCTGCCC
GTGGACGGGGGGATGACGGCGAGCTTCATGATGGCGGGGCGGCCGGTGTAG

# Drug_Target_24_General_Function:
Not Available

# Drug_Target_24_General_References:
15064768	Henne A, Bruggemann H, Raasch C, Wiezer A, Hartsch T, Liesegang H, Johann A, Lienard T, Gohl O, Martinez-Arias R, Jacobi C, Starkuviene V, Schlenczeck S, Dencker S, Huber R, Klenk HP, Kramer W, Merkl R, Gottschalk G, Fritz HJ: The genome sequence of the extreme thermophile Thermus thermophilus. Nat Biotechnol. 2004 May;22(5):547-53. Epub 2004 Apr 4.

# Drug_Target_24_HGNC_ID:
Not Available

# Drug_Target_24_HPRD_ID:
Not Available

# Drug_Target_24_ID:
6484

# Drug_Target_24_Locus:
Not Available

# Drug_Target_24_Molecular_Weight:
23728.6

# Drug_Target_24_Name:
Hypothetical conserved protein

# Drug_Target_24_Number_of_Residues:
224

# Drug_Target_24_PDB_ID:
Not Available

# Drug_Target_24_Pathway:
Not Available

# Drug_Target_24_Pfam_Domain_Function:
Not Available

# Drug_Target_24_Protein_Sequence:
>Hypothetical conserved protein
MKKGLLAALAGFLTLAMAQKFSVEAGAGFYGGFGGQLAVVAEDLAPGLPLGVRLGVGFAT
SDALDDGYDLGGGTTWGDVKEAGKFSEWGQNVTLSLDVLYKPSGLGLPVEVAPYFGVRYN
FFSGGYTDPEDNLTIKAQTISSNQLGLGLGVRAAYPLMPNLSLVGDLGVDYYFQACFTRV
EEDDSGNKSQSSVCPGDSGYEDVNKFVTQPEWVLKLRLGAAYRF

# Drug_Target_24_Reaction:
Not Available

# Drug_Target_24_Signals:
None

# Drug_Target_24_Specific_Function:
Not Available

# Drug_Target_24_SwissProt_ID:
Q72JD8

# Drug_Target_24_SwissProt_Name:
Q72JD8_THET2

# Drug_Target_24_Synonyms:
Not Available

# Drug_Target_24_Theoretical_pI:
4.25

# Drug_Target_24_Transmembrane_Regions:
None

# Drug_Target_25_Cellular_Location:
Cell outer membrane

# Drug_Target_25_Chromosome_Location:
Not Available

# Drug_Target_25_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_25_Essentiality:
Essential

# Drug_Target_25_GenAtlas_ID:
Not Available

# Drug_Target_25_GenBank_ID_Gene:
AF005091

# Drug_Target_25_GenBank_ID_Protein:
2218156

# Drug_Target_25_GeneCard_ID:
estA

# Drug_Target_25_Gene_Name:
estA

# Drug_Target_25_Gene_Sequence:
>1941 bp
ATGATCAGAATGGCGCTCAAGCCACTGGTAGCGGCCTGCCTGCTGGCTTCGCTGTCCACC
GCCCCGCAGGCTGCTCCTTCGCCCTATTCGACGCTGGTGGTGTTCGGCGACAGCCTCAGC
GATGCCGGGCAGTTCCCCGATCCTGCCGGCCCCGCCGGAAGCACCTCGCGTTTCACCAAC
CGGGTCGGCCCGACCTACCAGAACGGCAGCGGCGAGATCTTCGGACCGACCGCGCCCATG
CTGCTCGGCAATCAGCTCGGCATCGCCCCGGGTGACCTGGCTGCCTCGACCTCGCCGGTC
AACGCCCAGCAGGGCATCGCCGACGGCAACAACTGGGCGGTGGGCGGCTACCGGACCGAT
CAGATCTACGACTCGATCACCGCGGCCAACGGCTCGCTGATCGAGCGCGACAATACCCTC
CTGCGCAGCCGCGATGGCTACCTGGTGGACCGTGCCCGCCAGGGCCTGGGTGCCGACCCG
AACGCGTTGTACTACATCACCGGCGGCGGCAACGACTTTCTCCAGGGGCGCATCCTCAAC
GACGTCCAGGCCCAACAGGCCGCCGGTCGCCTGGTGGATAGCGTGCAGGCCCTGCAGCAG
GCCGGCGCGCGCTACATCGTGGTCTGGCTGTTGCCCGACCTGGGCCTGACCCCGGCTACC
TTCGGTGGTCCCTTGCAGCCTTTCGCCAGCCAACTCAGCGGCACGTTCAACGCCGAGCTG
ACCGCCCAGTTGAGCCAGGCCGGCGCCAACGTCATTCCGTTGAACATCCCGCTGCTGCTC
AAGGAAGGCATGGCCAACCCGGCTTCCTTCGGCCTGGCCGCCGACCAGAACCTGATCGGC
ACCTGTTTCAGCGGCAACGGCTGCACCATGAACCCGACCTACGGGATCAACGGCAGCACG
CCCGACCCGAGCAAATTGCTGTTCAACGACAGCGTGCACCCGACCATCACCGGCCAGCGC
CTGATCGCCGACTACACCTATTCGCTGCTGTCGGCGCCCTGGGAGCTGACCCTGCTGCCG
GAAATGGCCCACGGCACCCTGCGTGCCTACCAGGACGAACTGCGCAGCCAGTGGCAGGCG
GACTGGGAGAACTGGCAGAACGTCGGCCAGTGGCGCGGCTTCGTCGGCGGCGGTGGCCAG
CGCCTGGACTTCGACTCCCAGGACAGCGCCGCCAGCGGCGACGGCAACGGCTACAACCTG
ACCCTTGGTGGCAGCTACCGCATCGACGAGGCCTGGCGCGCCGGGGTCGCCGCCGGTTTC
TACCGGCAGAAGCTGGAAGCCGGCGCCAAGGATTCCGACTACCGGATGAACAGCTACATG
GCCAGCGCCTTCGTGCAGTACCAGGAAAACCGCTGGTGGGCCGACGCGGCGTTGACCGGC
GGCTACCTCGACTACGACGACCTGAAGCGCAAGTTCGCCCTGGGCGGCGGCGAGCGCAGC
GAGAAAGGCGACACCAACGGCCACCTGTGGGCGTTCAGCGCGCGCCTGGGCTACGACATC
GCCCAGCAGGCCGACAGTCCCTGGCACCTGTCGCCGTTCGTCAGCGCCGACTATGCACGG
GTCGAGGTCGACGGCTATTCCGAGAAGGGCGCCAGCGCCACCGCGCTCGACTACGACGAC
CAGAAGCGCAGCTCGAAGCGCCTGGGCGCCGGCCTGCAAGGCAAGTACGCGTTCGGCAGC
GATACCCAGCTGTTCGCCGAGTACGCCCACGAACGTGAGTACGAGGACGACACCCAGGAC
CTGACCATGTCCCTCAACAGCCTGCCGGGCAATCGCTTCACCCTCGAAGGCTACACCCCG
CAGGACCATCTCAACCGCGTCTCACTCGGCTTCAGCCAGAAGCTGGCGCCGGAGCTGTCG
CTGCGCGGCGGCTACAACTGGCGCAAGGGCGAGGACGATACCCAGCAGAGCGTCAGCCTG
GCGCTGAGCCTGGACTTCTGA

# Drug_Target_25_General_Function:
Lipid transport and metabolism

# Drug_Target_25_General_References:
10559163	Wilhelm S, Tommassen J, Jaeger KE: A novel lipolytic enzyme located in the outer membrane of Pseudomonas aeruginosa. J Bacteriol. 1999 Nov;181(22):6977-86.
10984043	Stover CK, Pham XQ, Erwin AL, Mizoguchi SD, Warrener P, Hickey MJ, Brinkman FS, Hufnagle WO, Kowalik DJ, Lagrou M, Garber RL, Goltry L, Tolentino E, Westbrock-Wadman S, Yuan Y, Brody LL, Coulter SN, Folger KR, Kas A, Larbig K, Lim R, Smith K, Spencer D, Wong GK, Wu Z, Paulsen IT, Reizer J, Saier MH, Hancock RE, Lory S, Olson MV: Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature. 2000 Aug 31;406(6799):959-64.

# Drug_Target_25_HGNC_ID:
Not Available

# Drug_Target_25_HPRD_ID:
Not Available

# Drug_Target_25_ID:
6485

# Drug_Target_25_Locus:
Not Available

# Drug_Target_25_Molecular_Weight:
69608.3

# Drug_Target_25_Name:
Esterase estA

# Drug_Target_25_Number_of_Residues:
646

# Drug_Target_25_PDB_ID:
Not Available

# Drug_Target_25_Pathway:
Not Available

# Drug_Target_25_Pfam_Domain_Function:
PF00657	Lipase_GDSL
PF03797	Autotransporter

# Drug_Target_25_Protein_Sequence:
>Esterase estA
MIRMALKPLVAACLLASLSTAPQAAPSPYSTLVVFGDSLSDAGQFPDPAGPAGSTSRFTN
RVGPTYQNGSGEIFGPTAPMLLGNQLGIAPGDLAASTSPVNAQQGIADGNNWAVGGYRTD
QIYDSITAANGSLIERDNTLLRSRDGYLVDRARQGLGADPNALYYITGGGNDFLQGRILN
DVQAQQAAGRLVDSVQALQQAGARYIVVWLLPDLGLTPATFGGPLQPFASQLSGTFNAEL
TAQLSQAGANVIPLNIPLLLKEGMANPASFGLAADQNLIGTCFSGNGCTMNPTYGINGST
PDPSKLLFNDSVHPTITGQRLIADYTYSLLSAPWELTLLPEMAHGTLRAYQDELRSQWQA
DWENWQNVGQWRGFVGGGGQRLDFDSQDSAASGDGNGYNLTLGGSYRIDEAWRAGVAAGF
YRQKLEAGAKDSDYRMNSYMASAFVQYQENRWWADAALTGGYLDYDDLKRKFALGGGERS
EKGDTNGHLWAFSARLGYDIAQQADSPWHLSPFVSADYARVEVDGYSEKGASATALDYDD
QKRSSKRLGAGLQGKYAFGSDTQLFAEYAHEREYEDDTQDLTMSLNSLPGNRFTLEGYTP
QDHLNRVSLGFSQKLAPELSLRGGYNWRKGEDDTQQSVSLALSLDF

# Drug_Target_25_Reaction:
Not Available

# Drug_Target_25_Signals:
1-24

# Drug_Target_25_Specific_Function:
A carboxylic ester + H(2)O = an alcohol + a carboxylate

# Drug_Target_25_SwissProt_ID:
O33407

# Drug_Target_25_SwissProt_Name:
ESTA_PSEAE

# Drug_Target_25_Synonyms:
Not Available

# Drug_Target_25_Theoretical_pI:
4.46

# Drug_Target_25_Transmembrane_Regions:
398-408
411-421
438-447
452-461
489-500
508-518
548-558
562-571
606-615
619-628
637-646

# Drug_Target_2_Cellular_Location:
Cell outer membrane
multi-pass membrane protein

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
V00307

# Drug_Target_2_GenBank_ID_Protein:
42160

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
ompA

# Drug_Target_2_Gene_Sequence:
>1041 bp
ATGAAAAAGACAGCTATCGCGATTGCAGTGGCACTGGCTGGTTTCGCTACCGTAGCGCAG
GCCGCTCCGAAAGATAACACCTGGTACACTGGTGCTAAACTGGGCTGGTCCCAGTACCAT
GATACTGGTTTCATCAACAACAATGGCCCGACCCATGAAAACCAACTGGGCGCTGGTGCT
TTTGGTGGTTACCAGGTTAACCCGTATGTTGGCTTTGAAATGGGTTACGACTGGTTAGGT
CGTATGCCGTACAAAGGCAGCGTTGAAAACGGTGCATACAAAGCTCAGGGCGTTCAACTG
ACCGCTAAACTGGGTTACCCAATCACTGACGACCTGGACATCTACACTCGTCTGGGTGGC
ATGGTATGGCGTGCAGACACTAAATCCAACGTTTATGGTAAAAACCACGACACCGGCGTT
TCTCCGGTCTTCGCTGGCGGTGTTGAGTACGCGATCACTCCTGAAATCGCTACCCGTCTG
GAATACCAGTGGACGAACAACATCGGTGACGCACACACCATCGGCACTCGTCCGGACAAC
GGCATGCTGAGCCTGGGTGTTTCCTACCGTTTCGGTCAGGGCGAGGCAGCTCCAGTAGTT
GCTCCGGCTCCAGCTCCGGCACCGGAAGTACAGACCAAGCACTTCACTCTGAAGTCTGAC
GTTCTGTTCAACTTCAACAAAGCAACCCTGAAACCGGAAGGTCAGGCTGCTCTGGATCAG
CTGTACAGCCAGCTGAGCAACTTGGATCCGAAAGACGGTTCCGTAGTTGTTCTGGGTTAC
ACCGACCGCATCGGTTCTGACGCTTACAACCAGGGTCTGTCCGAGCGCCGTGCTCAGTCT
GTTGTTGATTACCTGATCTCCAAAGGTATCCCGGCAGACAAGATCTCCGCACGTGGTATG
GGCGAATCCAACCCGGTTACTGGCAACACCTGTGACAACGTGAAACAGCGTGCTGCACTG
ATCGACTGCCTGGCTCCGGATCGTCGCGTAGAGATCGAAGTTAAAGGTATCAAAGACGTT
GTAACTCAGCCGCAGGCTTAA

# Drug_Target_2_General_Function:
Cell wall/membrane/envelope biogenesis

# Drug_Target_2_General_References:
10368142	Koebnik R: Structural and functional roles of the surface-exposed loops of the beta-barrel membrane protein OmpA from Escherichia coli. J Bacteriol. 1999 Jun;181(12):3688-94.
10757971	le Coutre J, Whitelegge JP, Gross A, Turk E, Wright EM, Kaback HR, Faull KF: Proteomics on full-length membrane proteins using mass spectrometry. Biochemistry. 2000 Apr 18;39(15):4237-42.
10764596	Pautsch A, Schulz GE: High-resolution structure of the OmpA membrane domain. J Mol Biol. 2000 Apr 28;298(2):273-82.
1370823	Sugawara E, Nikaido H: Pore-forming activity of OmpA protein of Escherichia coli. J Biol Chem. 1992 Feb 5;267(4):2507-11.
3902787	Morona R, Kramer C, Henning U: Bacteriophage receptor area of outer membrane protein OmpA of Escherichia coli K-12. J Bacteriol. 1985 Nov;164(2):539-43.
6086577	Morona R, Klose M, Henning U: Escherichia coli K-12 outer membrane protein (OmpA) as a bacteriophage receptor: analysis of mutant genes expressing altered proteins. J Bacteriol. 1984 Aug;159(2):570-8.
6253901	Beck E, Bremer E: Nucleotide sequence of the gene ompA coding the outer membrane protein II of Escherichia coli K-12. Nucleic Acids Res. 1980 Jul 11;8(13):3011-27.
6260961	Movva NR, Nakamura K, Inouye M: Gene structure of the OmpA protein, a major surface protein of Escherichia coli required for cell-cell interaction. J Mol Biol. 1980 Nov 5;143(3):317-28.
7001461	Chen R, Schmidmayr W, Kramer C, Chen-Schmeisser U, Henning U: Primary structure of major outer membrane protein II (ompA protein) of Escherichia coli K-12. Proc Natl Acad Sci U S A. 1980 Aug;77(8):4592-6.
8106193	Gromiha MM, Ponnuswamy PK: Prediction of transmembrane beta-strands from hydrophobic characteristics of proteins. Int J Pept Protein Res. 1993 Nov;42(5):420-31.
8905232	Oshima T, Aiba H, Baba T, Fujita K, Hayashi K, Honjo A, Ikemoto K, Inada T, Itoh T, Kajihara M, Kanai K, Kashimoto K, Kimura S, Kitagawa M, Makino K, Masuda S, Miki T, Mizobuchi K, Mori H, Motomura K, Nakamura Y, Nashimoto H, Nishio Y, Saito N, Horiuchi T, et al.: A 718-kb DNA sequence of the Escherichia coli K-12 genome corresponding to the 12.7-28.0 min region on the linkage map. DNA Res. 1996 Jun 30;3(3):137-55.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.
9298646	Link AJ, Robison K, Church GM: Comparing the predicted and observed properties of proteins encoded in the genome of Escherichia coli K-12. Electrophoresis. 1997 Aug;18(8):1259-313.
9629924	Molloy MP, Herbert BR, Walsh BJ, Tyler MI, Traini M, Sanchez JC, Hochstrasser DF, Williams KL, Gooley AA: Extraction of membrane proteins by differential solubilization for separation using two-dimensional gel electrophoresis. Electrophoresis. 1998 May;19(5):837-44.
9808047	Pautsch A, Schulz GE: Structure of the outer membrane protein A transmembrane domain. Nat Struct Biol. 1998 Nov;5(11):1013-7.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
3715

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
37201

# Drug_Target_2_Name:
Outer membrane protein A precursor

# Drug_Target_2_Number_of_Residues:
346

# Drug_Target_2_PDB_ID:
Not Available

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF00691	OmpA
PF01389	OmpA_membrane

# Drug_Target_2_Protein_Sequence:
>Outer membrane protein A precursor
MKKTAIAIAVALAGFATVAQAAPKDNTWYTGAKLGWSQYHDTGFINNNGPTHENQLGAGA
FGGYQVNPYVGFEMGYDWLGRMPYKGSVENGAYKAQGVQLTAKLGYPITDDLDIYTRLGG
MVWRADTKSNVYGKNHDTGVSPVFAGGVEYAITPEIATRLEYQWTNNIGDAHTIGTRPDN
GMLSLGVSYRFGQGEAAPVVAPAPAPAPEVQTKHFTLKSDVLFNFNKATLKPEGQAALDQ
LYSQLSNLDPKDGSVVVLGYTDRIGSDAYNQGLSERRAQSVVDYLISKGIPADKISARGM
GESNPVTGNTCDNVKQRAALIDCLAPDRRVEIEVKGIKDVVTQPQA

# Drug_Target_2_Reaction:
Not Available

# Drug_Target_2_Signals:
1-21

# Drug_Target_2_Specific_Function:
Required for the action of colicins K and L and for the stabilization of mating aggregates in conjugation. Serves as a receptor for a number of T-even like phages. Also acts as a porin with low permeability that allows slow penetration of small solutes

# Drug_Target_2_SwissProt_ID:
P0A910

# Drug_Target_2_SwissProt_Name:
OMPA_ECOLI

# Drug_Target_2_Synonyms:
Outer membrane protein II*

# Drug_Target_2_Theoretical_pI:
6.37

# Drug_Target_2_Transmembrane_Regions:
27-37
55-66
70-78
96-107
112-124
138-151
156-163
182-190

# Drug_Target_3_Cellular_Location:
Cell outer membrane
multi-pass membrane protein

# Drug_Target_3_Chromosome_Location:
Not Available

# Drug_Target_3_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_3_Essentiality:
Non-Essential

# Drug_Target_3_GenAtlas_ID:
Not Available

# Drug_Target_3_GenBank_ID_Gene:
Not Available

# Drug_Target_3_GenBank_ID_Protein:
Not Available

# Drug_Target_3_GeneCard_ID:
Not Available

# Drug_Target_3_Gene_Name:
opmA

# Drug_Target_3_Gene_Sequence:
Not Available

# Drug_Target_3_General_Function:
Not Available

# Drug_Target_3_General_References:
7525973	Kreusch A, Schulz GE: Refined structure of the porin from Rhodopseudomonas blastica. Comparison with the porin from Rhodobacter capsulatus. J Mol Biol. 1994 Nov 11;243(5):891-905.
8142898	Kreusch A, Neubuser A, Schiltz E, Weckesser J, Schulz GE: Structure of the membrane channel porin from Rhodopseudomonas blastica at 2.0 A resolution. Protein Sci. 1994 Jan;3(1):58-63.
9684893	Schmid B, Maveyraud L, Kromer M, Schulz GE: Porin mutants with new channel properties. Protein Sci. 1998 Jul;7(7):1603-11.

# Drug_Target_3_HGNC_ID:
Not Available

# Drug_Target_3_HPRD_ID:
Not Available

# Drug_Target_3_ID:
2961

# Drug_Target_3_Locus:
Not Available

# Drug_Target_3_Molecular_Weight:
30597

# Drug_Target_3_Name:
Porin

# Drug_Target_3_Number_of_Residues:
289

# Drug_Target_3_PDB_ID:
1PRN

# Drug_Target_3_Pathway:
Not Available

# Drug_Target_3_Pfam_Domain_Function:
Not Available

# Drug_Target_3_Protein_Sequence:
>Porin
EISLNGYGRFGLQYVEDRGVGLEDTIISSRLRINIVGTTETDQGVTFGAKLRMQWDDGDA
FAGTAGNAAQFWTSYNGVTVSVGNVDTAFDSVALTYDSEMGYEASSFGDAQSSFFAYNSK
YDASGALDNYNGIAVTYSISGVNLYLSYVDPDQTVDSSLVTEEFGIAADWSNDMISLAAA
YTTDAGGIVDNDIAFVGAAYKFNDAGTVGLNWYDNGLSTAGDQVTLYGNYAFGATTVRAY
VSDIDRAGADTAYGIGADYQFAEGVKVSGSVQSGFANETVADVGVRFDF

# Drug_Target_3_Reaction:
Not Available

# Drug_Target_3_Signals:
None

# Drug_Target_3_Specific_Function:
Forms channels that allow the passive diffusion of small hydrophilic solutes up to an exclusion limit of about 0.6 kDa

# Drug_Target_3_SwissProt_ID:
P39767

# Drug_Target_3_SwissProt_Name:
PORI_RHOBL

# Drug_Target_3_Synonyms:
Not Available

# Drug_Target_3_Theoretical_pI:
3.62

# Drug_Target_3_Transmembrane_Regions:
None

# Drug_Target_4_Cellular_Location:
Cell outer membrane
multi-pass membrane protein

# Drug_Target_4_Chromosome_Location:
Not Available

# Drug_Target_4_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_4_Essentiality:
Non-Essential

# Drug_Target_4_GenAtlas_ID:
Not Available

# Drug_Target_4_GenBank_ID_Gene:
J01655

# Drug_Target_4_GenBank_ID_Protein:
147010

# Drug_Target_4_GeneCard_ID:
Not Available

# Drug_Target_4_Gene_Name:
ompF

# Drug_Target_4_Gene_Sequence:
>1089 bp
ATGATGAAGCGCAATATTCTGGCAGTGATCGTCCCTGCTCTGTTAGTAGCAGGTACTGCA
AACGCTGCAGAAATCTATAACAAAGATGGCAACAAAGTAGATCTGTACGGTAAAGCTGTT
GGTCTGCATTATTTTTCCAAGGGTAACGGTGAAAACAGTTACGGTGGCAATGGCGACATG
ACCTATGCCCGTCTTGGTTTTAAAGGGGAAACTCAAATCAATTCCGATCTGACCGGTTAT
GGTCAGTGGGAATATAACTTCCAGGGTAACAACTCTGAAGGCGCTGACGCTCAAACTGGT
AACAAAACGCGTCTGGCATTCGCGGGTCTTAAATACGCTGACGTTGGTTCTTTCGATTAC
GGCCGTAACTACGGTGTGGTTTATGATGCACTGGGTTACACCGATATGCTGCCAGAATTT
GGTGGTGATACTGCATACAGCGATGACTTCTTCGTTGGTCGTGTTGGCGGCGTTGCTACC
TATCGTAACTCCAACTTCTTTGGTCTGGTTGATGGCCTGAACTTCGCTGTTCAGTACCTG
GGTAAAAACGAGCGTGACACTGCACGCCGTTCTAACGGCGACGGTGTTGGCGGTTCTATC
AGCTACGAATACGAAGGCTTTGGTATCGTTGGTGCTTATGGTGCAGCTGACCGTACCAAC
CTGCAAGAAGCTCAACCTCTTGGCAACGGTAAAAAAGCTGAACAGTGGGCTACTGGTCTG
AAGTACGACGCGAACAACATCTACCTGGCAGCGAACTACGGTGAAACCCGTAACGCTACG
CCGATCACTAATAAATTTACAAACACCAGCGGCTTCGCCAACAAAACGCAAGACGTTCTG
TTAGTTGCGCAATACCAGTTCGATTTCGGTCTGCGTCCGTCCATCGCTTACACCAAATCT
AAAGCGAAAGACGTAGAAGGTATCGGTGATGTTGATCTGGTGAACTACTTTGAAGTGGGC
GCAACCTACTACTTCAACAAAAACATGTCCACCTATGTTGACTACATCATCAACCAGATC
GATTCTGACAACAAACTGGGCGTAGGTTCAGACGACACCGTTGCTGTGGGTATCGTTTAC
CAGTTCTAA

# Drug_Target_4_General_Function:
Cell wall/membrane/envelope biogenesis

# Drug_Target_4_General_References:
1380671	Cowan SW, Schirmer T, Rummel G, Steiert M, Ghosh R, Pauptit RA, Jansonius JN, Rosenbusch JP: Crystal structures explain functional properties of two E. coli porins. Nature. 1992 Aug 27;358(6389):727-33.
2997131	Nogami T, Mizuno T, Mizushima S: Construction of a series of ompF-ompC chimeric genes by in vivo homologous recombination in Escherichia coli and characterization of the translational products. J Bacteriol. 1985 Nov;164(2):797-801.
6294623	Inokuchi K, Mutoh N, Matsuyama S, Mizushima S: Primary structure of the ompF gene that codes for a major outer membrane protein of Escherichia coli K-12. Nucleic Acids Res. 1982 Nov 11;10(21):6957-68.
7037455	Mutoh N, Inokuchi K, Mizushima S: Amino acid sequence of the signal peptide of OmpF, a major outer membrane protein of Escherichia coli. FEBS Lett. 1982 Jan 25;137(2):171-4.
7049161	Chen R, Kramer C, Schmidmayr W, Chen-Schmeisser U, Henning U: Primary structure of major outer-membrane protein I (ompF protein, porin) of Escherichia coli B/r. Biochem J. 1982 Apr 1;203(1):33-43.
7524100	Jeanteur D, Schirmer T, Fourel D, Simonet V, Rummel G, Widmer C, Rosenbusch JP, Pattus F, Pages JM: Structural and functional alterations of a colicin-resistant mutant of OmpF porin from Escherichia coli. Proc Natl Acad Sci U S A. 1994 Oct 25;91(22):10675-9.
8905232	Oshima T, Aiba H, Baba T, Fujita K, Hayashi K, Honjo A, Ikemoto K, Inada T, Itoh T, Kajihara M, Kanai K, Kashimoto K, Kimura S, Kitagawa M, Makino K, Masuda S, Miki T, Mizobuchi K, Mori H, Motomura K, Nakamura Y, Nashimoto H, Nishio Y, Saito N, Horiuchi T, et al.: A 718-kb DNA sequence of the Escherichia coli K-12 genome corresponding to the 12.7-28.0 min region on the linkage map. DNA Res. 1996 Jun 30;3(3):137-55.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.
9298646	Link AJ, Robison K, Church GM: Comparing the predicted and observed properties of proteins encoded in the genome of Escherichia coli K-12. Electrophoresis. 1997 Aug;18(8):1259-313.
9629924	Molloy MP, Herbert BR, Walsh BJ, Tyler MI, Traini M, Sanchez JC, Hochstrasser DF, Williams KL, Gooley AA: Extraction of membrane proteins by differential solubilization for separation using two-dimensional gel electrophoresis. Electrophoresis. 1998 May;19(5):837-44.
9843370	Phale PS, Philippsen A, Kiefhaber T, Koebnik R, Phale VP, Schirmer T, Rosenbusch JP: Stability of trimeric OmpF porin: the contributions of the latching loop L2. Biochemistry. 1998 Nov 10;37(45):15663-70.

# Drug_Target_4_HGNC_ID:
Not Available

# Drug_Target_4_HPRD_ID:
Not Available

# Drug_Target_4_ID:
2863

# Drug_Target_4_Locus:
Not Available

# Drug_Target_4_Molecular_Weight:
39334

# Drug_Target_4_Name:
Outer membrane protein F

# Drug_Target_4_Number_of_Residues:
362

# Drug_Target_4_PDB_ID:
1OPF

# Drug_Target_4_Pathway:
Not Available

# Drug_Target_4_Pfam_Domain_Function:
PF00267	Porin_1

# Drug_Target_4_Protein_Sequence:
>Outer membrane protein F precursor
MMKRNILAVIVPALLVAGTANAAEIYNKDGNKVDLYGKAVGLHYFSKGNGENSYGGNGDM
TYARLGFKGETQINSDLTGYGQWEYNFQGNNSEGADAQTGNKTRLAFAGLKYADVGSFDY
GRNYGVVYDALGYTDMLPEFGGDTAYSDDFFVGRVGGVATYRNSNFFGLVDGLNFAVQYL
GKNERDTARRSNGDGVGGSISYEYEGFGIVGAYGAADRTNLQEAQPLGNGKKAEQWATGL
KYDANNIYLAANYGETRNATPITNKFTNTSGFANKTQDVLLVAQYQFDFGLRPSIAYTKS
KAKDVEGIGDVDLVNYFEVGATYYFNKNMSTYVDYIINQIDSDNKLGVGSDDTVAVGIVY
QF

# Drug_Target_4_Reaction:
Not Available

# Drug_Target_4_Signals:
1-22

# Drug_Target_4_Specific_Function:
OmpF is a porin that forms passive diffusion pores which allow small molecular weight hydrophilic materials across the outer membrane. It is also a receptor for the bacteriophage T2

# Drug_Target_4_SwissProt_ID:
P02931

# Drug_Target_4_SwissProt_Name:
OMPF_ECOLI

# Drug_Target_4_Synonyms:
Outer membrane protein 1A
Outer membrane protein B
Outer membrane protein F precursor
Outer membrane protein IA
Porin ompF

# Drug_Target_4_Theoretical_pI:
4.53

# Drug_Target_4_Transmembrane_Regions:
23-28
30-45
61-73
76-88
105-113
116-122
157-163
172-181
194-204
206-217
233-244
246-257
275-287
290-303
314-325
328-337
353-362

# Drug_Target_5_Cellular_Location:
Cell outer membrane
multi-pass membrane protein

# Drug_Target_5_Chromosome_Location:
Not Available

# Drug_Target_5_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_5_Essentiality:
Non-Essential

# Drug_Target_5_GenAtlas_ID:
Not Available

# Drug_Target_5_GenBank_ID_Gene:
M60607

# Drug_Target_5_GenBank_ID_Protein:
145910

# Drug_Target_5_GeneCard_ID:
Not Available

# Drug_Target_5_Gene_Name:
fadL

# Drug_Target_5_Gene_Sequence:
>1347 bp
ATGGTCATGAGCCAGAAAACCCTGTTTACAAAGTCTGCTCTCGCAGTCGCAGTGGCACTT
ATCTCCACCCAGGCCTGGTCGGCAGGCTTTCAGTTAAACGAATTTTCTTCCTCTGGCCTG
GGCCGGGCTTATTCAGGGGAAGGCGCAATTGCCGATGATGCAGGTAACGTCAGCCGTAAC
CCCGCATTGATTACTATGTTTGACCGCCCGACATTTTCTGCGGGTGCGGTTTATATTGAC
CCGGATGTAAATATCAGCGGAACGTCTCCATCTGGTCGTAGCCTGAAAGCCGATAACATC
GCGCCTACGGCATGGGTTCCGAACATGCACTTTGTTGCACCGATTAACGACCAATTTGGT
TGGGGCGCTTCTATTACCTCTAACTATGGTCTGGCTACAGAGTTTAACGATACTTATGCA
GGCGGCTCTGTCGGGGGTACAACCGACCTTGAAACCATGAACCTGAACTTAAGCGGTGCG
TATCGCTTAAATAATGCATGGAGCTTTGGTCTTGGTTTCAACGCCGTCTACGTCCGCGCG
AAAATTGAACGTTTCGCAGGCGATCTGGGGCAGTTGGTTGCTGGCCAAATTATGCAATCT
CCTGCTGGCCAAACTCAGCAAGGGCAAGCATTGGCAGCTACCGCCAACGGTATTGACAGT
AATACCAAAATCGCTCATCTGAACGGTAACCAGTGGGGCTTTGGCTGGAACGCCGGAATC
CTGTATGAACTGGATAAAAATAACCGCTATGCACTGACCTACCGTTCTGAAGTGAAAATT
GACTTCAAAGGTAACTACAGCAGCGATCTTAATCGTGCGTTTAATAACTACGGTTTGCCA
ATTCCTACCGCGACAGGTGGCCGAACGCAATCGGGTTATCTGACGCTGAACCTGCCTGAA
ATGTGGGAAGTGTCAGGTTATAACCGTGTTGATCCACAGTGGGCGATTCACTATAGCCTG
GCTTACACCAGCTGGAGTCAGTTCCAGCAGCTGAAAGCGACCTCAACCAGTGGCGACACG
CTGTTCCAGAAACATGAAGGCTTTAAAGATGCTTACCGCATCGCGTTGGGTACCACTTAT
TACTACGATGATAACTGGACCTTCCGTACCGGTATCGCCTTTGATGACAGCCCAGTTCCT
GCACAGAATCGTTCTATCTCCATTCCGGACCAGGACCGTTTCTGGCTGAGTGCAGGTACG
ACTTACGCATTTAATAAAGATGCTTCAGTCGACGTTGGTGTTTCTTATATGCACGGTCAG
AGCGTGAAAATTAACGAAGGCCCATACCAGTTCGAGTCTGAAGGTAAAGCCTGGCTGTTC
GGTACTAACTTTAACTACGCGTTCTGA

# Drug_Target_5_General_Function:
Lipid transport and metabolism

# Drug_Target_5_General_References:
1987139	Black PN: Primary sequence of the Escherichia coli fadL gene encoding an outer membrane protein required for long-chain fatty acid transport. J Bacteriol. 1991 Jan;173(2):435-42.
2840553	Said B, Ghosn CR, Vu L, Nunn WD: Nucleotide sequencing and expression of the fadL gene involved in long-chain fatty acid transport in Escherichia coli. Mol Microbiol. 1988 May;2(3):363-70.
9205837	Yamamoto Y, Aiba H, Baba T, Hayashi K, Inada T, Isono K, Itoh T, Kimura S, Kitagawa M, Makino K, Miki T, Mitsuhashi N, Mizobuchi K, Mori H, Nakade S, Nakamura Y, Nashimoto H, Oshima T, Oyama S, Saito N, Sampei G, Satoh Y, Sivasundaram S, Tagami H, Horiuchi T, et al.: Construction of a contiguous 874-kb sequence of the Escherichia coli -K12 genome corresponding to 50.0-68.8 min on the linkage map and analysis of its sequence features. DNA Res. 1997 Apr 28;4(2):91-113.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.

# Drug_Target_5_HGNC_ID:
Not Available

# Drug_Target_5_HPRD_ID:
Not Available

# Drug_Target_5_ID:
2925

# Drug_Target_5_Locus:
Not Available

# Drug_Target_5_Molecular_Weight:
48542

# Drug_Target_5_Name:
Long-chain fatty acid transport protein

# Drug_Target_5_Number_of_Residues:
446

# Drug_Target_5_PDB_ID:
1T1L

# Drug_Target_5_Pathway:
Not Available

# Drug_Target_5_Pfam_Domain_Function:
PF03349	Toluene_X

# Drug_Target_5_Protein_Sequence:
>Long-chain fatty acid transport protein precursor
MSQKTLFTKSALAVAVALISTQAWSAGFQLNEFSSSGLGRAYSGEGAIADDAGNVSRNPA
LITMFDRPTFSAGAVYIDPDVNISGTSPSGRSLKADNIAPTAWVPNMHFVAPINDQFGWG
ASITSNYGLATEFNDTYAGGSVGGTTDLETMNLNLSGAYRLNNAWSFGLGFNAVYARAKI
ERFAGDLGQLVAGQIMQSPAGQTQQGQALAATANGIDSNTKIAHLNGNQWGFGWNAGILY
ELDKNNRYALTYRSEVKIDFKGNYSSDLNRAFNNYGLPIPTATGGATQSGYLTLNLPEMW
EVSGYNRVDPQWAIHYSLAYTSWSQFQQLKATSTSGDTLFQKHEGFKDAYRIALGTTYYY
DDNWTFRTGIAFDDSPVPAQNRSISIPDQDRFWLSAGTTYAFNKDASVDVGVSYMHGQSV
KINEGPYQFESEGKAWLFGTNFNYAF

# Drug_Target_5_Reaction:
Not Available

# Drug_Target_5_Signals:
1-25

# Drug_Target_5_Specific_Function:
Involved in translocation of long-chain fatty acids across the outer membrane. It is a receptor for the bacteriophage T2. FadL may form a specific channel

# Drug_Target_5_SwissProt_ID:
P10384

# Drug_Target_5_SwissProt_Name:
FADL_ECOLI

# Drug_Target_5_Synonyms:
Long-chain fatty acid transport protein precursor
Outer membrane fadL protein
Outer membrane flp protein

# Drug_Target_5_Theoretical_pI:
4.90

# Drug_Target_5_Transmembrane_Regions:
None

# Drug_Target_6_Cellular_Location:
Cell membrane
peripheral membrane protein

# Drug_Target_6_Chromosome_Location:
Not Available

# Drug_Target_6_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_6_Essentiality:
Non-Essential

# Drug_Target_6_GenAtlas_ID:
Not Available

# Drug_Target_6_GenBank_ID_Gene:
M73834

# Drug_Target_6_GenBank_ID_Protein:
987617

# Drug_Target_6_GeneCard_ID:
Not Available

# Drug_Target_6_Gene_Name:
shc

# Drug_Target_6_Gene_Sequence:
>1896 bp
ATGGCTGAGCAGTTGGTGGAAGCGCCGGCCTACGCGCGGACGCTGGATCGCGCGGTGGAG
TATCTCCTCTCCTGCCAAAAGGACGAAGGCTACTGGTGGGGGCCGCTTCTGAGCAACGTC
ACGATGGAAGCGGAGTACGTCCTCTTGTGCCACATTCTCGATCGCGTCGATCGGGATCGC
ATGGAGAAGATCCGGCGGTACCTGTTGCACGAGCAGCGCGAGGACGGCACGTGGGCCCTG
TACCCGGGTGGGCCGCCGGACCTCGACACGACCATCGAGGCGTACGTCGCGCTCAAGTAT
ATCGGCATGTCGCGCGACGAGGAGCCGATGCAGAAGGCGCTCCGGTTCATTCAGAGCCAG
GGCGGGATCGAGTCGTCGCGCGTGTTCACGCGGATGTGGCTGGCGCTGGTGGGAGAATAT
CCGTGGGAGAAGGTGCCCATGGTCCCGCCGGAGATCATGTTCCTCGGCAAGCGCATGCCG
CTCAACATCTACGAGTTTGGCTCGTGGGCTCGGGCGACCGTCGTGGCGCTCTCGATTGTG
ATGAGCCGCCAGCCGGTGTTCCCGCTGCCCGAGCGGGCGCGCGTGCCCGAGCTGTACGAG
ACCGACGTGCCTCCGCGCCGGCGCGGCGCCAAGGGAGGGGGTGGGTGGATCTTCGACGCG
CTCGACCGGGCGCTGCACGGGTATCAGAAGCTGTCGGTGCACCCGTTCCGCCGCGCGGCC
GAGATCCGCGCCTTGGACTGGTTGCTCGAGCGCCAGGCCGGAGACGGCAGCTGGGGCGGG
ATTCAGCCGCCTTGGTTTTACGCGCTCATCGCGCTCAAGATTCTCGACATGACGCAGCAT
CCGGCGTTCATCAAGGGCTGGGAAGGTCTAGAGCTGTACGGCGTGGAGCTGGATTACGGA
GGATGGATGTTTCAGGCTTCCATCTCGCCGGTGTGGGACACGGGCCTCGCCGTGCTCGCG
CTGCGCGCTGCGGGGCTTCCGGCCGATCACGACCGCTTGGTCAAGGCGGGCGAGTGGCTG
TTGGACCGGCAGATCACGGTTCCGGGCGACTGGGCGGTGAAGCGCCCGAACCTCAAGCCG
GGCGGGTTCGCGTTCCAGTTCGACAACGTGTACTACCCGGACGTGGACGACACGGCCGTC
GTGGTGTGGGCGCTCAACACCCTGCGCTTGCCGGACGAGCGCCGCAGGCGGGACGCCATG
ACGAAGGGATTCCGCTGGATTGTCGGCATGCAGAGCTCGAACGGCGGTTGGGGCGCCTAC
GACGTCGACAACACGAGCGATCTCCCGAACCACATCCCGTTCTGCGACTTCGGCGAAGTG
ACCGATCCGCCGTCAGAGGACGTCACCGCCCACGTGCTCGAGTGTTTCGGCAGCTTCGGG
TACGATGACGCCTGGAAGGTCATCCGGCGCGCGGTGGAATATCTCAAGCGGGAGCAGAAG
CCGGACGGCAGCTGGTTCGGTCGTTGGGGCGTCAATTACCTCTACGGCACGGGCGCGGTG
GTGTCGGCGCTGAAGGCGGTCGGGATCGACACGCGCGAGCCGTACATTCAAAAGGCGCTC
GACTGGGTCGAGCAGCATCAGAACCCGGACGGCGGCTGGGGCGAGGACTGCCGCTCGTAC
GAGGATCCGGCGTACGCGGGTAAGGGCGCGAGCACCCCGTCGCAGACGGCCTGGGCGCTG
ATGGCGCTCATCGCGGGCGGCAGGGCGGAGTCCGAGGCCGCGCGCCGCGGCGTGCAATAC
CTCGTGGAGACGCAGCGCCCGGACGGCGGCTGGGATGAGCCGTACTACACCGGCACGGCT
TCCCCAGGGGATTTCTACCTCGGCTACACCATGTACCGCCACGTGTTTCCGACGCTCGCG
CTCGGCCGCTACAAGCAAGCCATCGAGCGCAGGTGA

# Drug_Target_6_General_Function:
Lipid transport and metabolism

# Drug_Target_6_General_References:
1729216	Ochs D, Kaletta C, Entian KD, Beck-Sickinger A, Poralla K: Cloning, expression, and sequencing of squalene-hopene cyclase, a key enzyme in triterpenoid metabolism. J Bacteriol. 1992 Jan;174(1):298-302.
2253626	Ochs D, Tappe CH, Gartner P, Kellner R, Poralla K: Properties of purified squalene-hopene cyclase from Bacillus acidocaldarius. Eur J Biochem. 1990 Nov 26;194(1):75-80.
9295270	Wendt KU, Poralla K, Schulz GE: Structure and function of a squalene cyclase. Science. 1997 Sep 19;277(5333):1811-5.
9532806	Sato T, Kanai Y, Hoshino T: Overexpression of squalene-hopene cyclase by the pET vector in Escherichia coli and first identification of tryptophan and aspartic acid residues inside the QW motif as active sites. Biosci Biotechnol Biochem. 1998 Feb;62(2):407-11.
9931258	Wendt KU, Lenhart A, Schulz GE: The structure of the membrane protein squalene-hopene cyclase at 2.0 A resolution. J Mol Biol. 1999 Feb 12;286(1):175-87.

# Drug_Target_6_HGNC_ID:
Not Available

# Drug_Target_6_HPRD_ID:
Not Available

# Drug_Target_6_ID:
2828

# Drug_Target_6_Locus:
Not Available

# Drug_Target_6_Molecular_Weight:
71571

# Drug_Target_6_Name:
Squalene--hopene cyclase

# Drug_Target_6_Number_of_Residues:
631

# Drug_Target_6_PDB_ID:
1UMP

# Drug_Target_6_Pathway:
Not Available

# Drug_Target_6_Pfam_Domain_Function:
PF00432	Prenyltrans

# Drug_Target_6_Protein_Sequence:
>Squalene--hopene cyclase
MAEQLVEAPAYARTLDRAVEYLLSCQKDEGYWWGPLLSNVTMEAEYVLLCHILDRVDRDR
MEKIRRYLLHEQREDGTWALYPGGPPDLDTTIEAYVALKYIGMSRDEEPMQKALRFIQSQ
GGIESSRVFTRMWLALVGEYPWEKVPMVPPEIMFLGKRMPLNIYEFGSWARATVVALSIV
MSRQPVFPLPERARVPELYETDVPPRRRGAKGGGGWIFDALDRALHGYQKLSVHPFRRAA
EIRALDWLLERQAGDGSWGGIQPPWFYALIALKILDMTQHPAFIKGWEGLELYGVELDYG
GWMFQASISPVWDTGLAVLALRAAGLPADHDRLVKAGEWLLDRQITVPGDWAVKRPNLKP
GGFAFQFDNVYYPDVDDTAVVVWALNTLRLPDERRRRDAMTKGFRWIVGMQSSNGGWGAY
DVDNTSDLPNHIPFCDFGEVTDPPSEDVTAHVLECFGSFGYDDAWKVIRRAVEYLKREQK
PDGSWFGRWGVNYLYGTGAVVSALKAVGIDTREPYIQKALDWVEQHQNPDGGWGEDCRSY
EDPAYAGKGASTPSQTAWALMALIAGGRAESEAARRGVQYLVETQRPDGGWDEPYYTGTG
FPGDFYLGYTMYRHVFPTLALGRYKQAIERR

# Drug_Target_6_Reaction:
(1) squalene = hop-22(29)-ene

# Drug_Target_6_Signals:
None

# Drug_Target_6_Specific_Function:
Catalyzes the cyclization of squalene into hopene

# Drug_Target_6_SwissProt_ID:
P33247

# Drug_Target_6_SwissProt_Name:
SQHC_ALIAD

# Drug_Target_6_Synonyms:
EC 5.4.99.17

# Drug_Target_6_Theoretical_pI:
5.17

# Drug_Target_6_Transmembrane_Regions:
None

# Drug_Target_7_Cellular_Location:
Cell outer membrane
multi-pass membrane protein

# Drug_Target_7_Chromosome_Location:
Not Available

# Drug_Target_7_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_7_Essentiality:
Non-Essential

# Drug_Target_7_GenAtlas_ID:
Not Available

# Drug_Target_7_GenBank_ID_Gene:
M10112

# Drug_Target_7_GenBank_ID_Protein:
145440

# Drug_Target_7_GeneCard_ID:
Not Available

# Drug_Target_7_Gene_Name:
btuB

# Drug_Target_7_Gene_Sequence:
>1845 bp
ATGATTAAAAAAGCTTCCCTGCTGACGGCGTGTTCCGTCACGGCATTTTCCGCTTGGGCA
CAGGATACCAGCCCGGATACTCTCGTCGTTACTGCTAACCGTTTTGAACAGCCGCGCAGC
ACTGTGCTTGCACCAACCACCGTTGTGACCCGTCAGGATATCGACCGCTGGCAGTCGACC
TCGGTCAATGATGTGCTGCGCCGTCTTCCGGGCGTCGATATCACCCAAAACGGCGGTTCA
GGTCAGCTCTCATCTATTTTTATTCGCGGTACAAATGCCAGTCATGTGTTGGTGTTAATT
GATGGCGTACGCCTGAATCTGGCGGGGGTGAGTGGTTCTGCCGACCTTAGCCAGTTCCCT
ATTGCGCTTGTCCAGCGTGTTGAATATATCCGTGGGCCGCGCTCCGCTGTTTATGGTTCC
GATGCAATAGGCGGGGTGGTGAATATCATCACGACGCGCGATGAACCCGGAACGGAAATT
TCAGGAGGGTGGGGAAGCAATAGTTATCAGAACTATGATGTCTCTACGCAGCAACAACTG
GGGGATAAGACACGGGTAACGCTGTTGGGCGATTATGCCCATACTCATGGTTATGATGTT
GTTGCCTATGGTAATACCGGAACGCAAGCGCAGACAGATAACGATGGTTTTTTAAGTAAA
ACGCTTTATGGCGCGCTGGAGCATAACTTTACTGATGCCTGGAGCGGCTTTGTGCGCGGC
TATGGCTATGATAACCGTACCAATTATGACGCGTATTATTCTCCCGGTTCACCGTTGCTC
GATACCCGTAAACTCTATAGCCAAAGTTGGGACGCCGGGCTGCGCTATAACGGCGAACTG
ATTAAATCACAACTCATTACCAGCTATAGCCATAGCAAAGATTACAACTACGATCCCCAT
TATGGTCGTTATGATTCGTCGGCGACGCTCGATGAGATGAAGCAATACACCGTCCAGTGG
GCAAACAATGTCATCGTTGGTCACGGTAGTATTGGTGCGGGTGTCGACTGGCAGAAACAG
ACTACGACGCCGGGTACAGGTTATGTTGAGGATGGATATGATCAACGTAATACCGGCATC
TATCTGACCGGGCTGCAACAAGTCGGCGATTTTACCTTTGAAGGCGCCAGACGCAGTGAC
GATAACTCACAGTTTGGTCGTCATGGAACCTGGCAAACCAGCGCCGGTTGGGAATTCATC
GAAGGTTATCGCTTCATTGCTTCCTACGGGACATCTTATAAGGCACCAAATCTGGGGCAA
CTGTATGGCTTCTACGGAAATCCGAATCTGGACCCGGAGAAAAGCAAACAGTGGGAAGGC
GCGTTTGAAGGCTTAACCGCTGGGGTGAACTGGCGTATTTCCGGATATCGTAACGATGTC
AGTGACTTGATCGATTATGATGATCACACCCTGAAATATTACAACGAAGGGAAAGCGCGG
ATTAAGGGCGTCGAGGCGACCGCCAATTTTGATACCGGACCACTGACGCATACTGTGAGT
TATGATTATGTCGATGCGCGCAATGCGATTACCGACACGCCGTTGTTACGCCGTGCTAAA
CAGCAGGTGAAATACCAGCTCGACTGGCAGTTGTATGACTTCGACTGGGGTATTACTTAT
CAGTATTTAGGCACTCGCTATGATAAGGATTACTCATCTTATCCTTATCAAACCGTTAAA
ATGGGCGGTGTGAGCTTGTGGGATCTTGCGGTTGCGTATCCGGTCACCTCTCACCTGACA
GTTCGTGGTAAAATAGCCAACCTGTTCGACAAAGATTATGAGACAGTCTATGGCTACCAA
ACTGCAGGACGGGAATACACCTTGTCTGGCAGCTACACCTTCTGA

# Drug_Target_7_General_Function:
Coenzyme transport and metabolism

# Drug_Target_7_General_References:
10485884	Cadieux N, Kadner RJ: Site-directed disulfide bonding reveals an interaction site between energy-coupling protein TonB and BtuB, the outer membrane cobalamin transporter. Proc Natl Acad Sci U S A. 1999 Sep 14;96(19):10673-8.
11705387	Coggshall KA, Cadieux N, Piedmont C, Kadner RJ, Cafiso DS: Transport-defective mutations alter the conformation of the energy-coupling motif of an outer membrane transporter. Biochemistry. 2001 Nov 20;40(46):13964-71.
12595710	Chimento DP, Mohanty AK, Kadner RJ, Wiener MC: Crystallization and initial X-ray diffraction of BtuB, the integral membrane cobalamin transporter of Escherichia coli. Acta Crystallogr D Biol Crystallogr. 2003 Mar;59(Pt 3):509-11. Epub 2003 Feb 21.
12652322	Chimento DP, Mohanty AK, Kadner RJ, Wiener MC: Substrate-induced transmembrane signaling in the cobalamin transporter BtuB. Nat Struct Biol. 2003 May;10(5):394-401.
14499604	Chimento DP, Kadner RJ, Wiener MC: The Escherichia coli outer membrane cobalamin transporter BtuB: structural analysis of calcium and substrate binding, and identification of orthologous transporters by sequence/structure conservation. J Mol Biol. 2003 Oct 3;332(5):999-1014.
1999392	Gustafsson C, Lindstrom PH, Hagervall TG, Esberg KB, Bjork GR: The trmA promoter has regulatory features and sequence elements in common with the rRNA P1 promoter family of Escherichia coli. J Bacteriol. 1991 Mar;173(5):1757-64.
2687240	Gudmundsdottir A, Bell PE, Lundrigan MD, Bradbeer C, Kadner RJ: Point mutations in a conserved region (TonB box) of Escherichia coli outer membrane protein BtuB affect vitamin B12 transport. J Bacteriol. 1989 Dec;171(12):6526-33.
3882670	Heller K, Kadner RJ: Nucleotide sequence of the gene for the vitamin B12 receptor protein in the outer membrane of Escherichia coli. J Bacteriol. 1985 Mar;161(3):904-8.
8093236	Dougherty TJ, Thanassi JA, Pucci MJ: The Escherichia coli mutant requiring D-glutamic acid is the result of mutations in two distinct genetic loci. J Bacteriol. 1993 Jan;175(1):111-6.
8265357	Blattner FR, Burland V, Plunkett G 3rd, Sofia HJ, Daniels DL: Analysis of the Escherichia coli genome. IV. DNA sequence of the region from 89.2 to 92.8 minutes. Nucleic Acids Res. 1993 Nov 25;21(23):5408-17.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.
9298646	Link AJ, Robison K, Church GM: Comparing the predicted and observed properties of proteins encoded in the genome of Escherichia coli K-12. Electrophoresis. 1997 Aug;18(8):1259-313.
9852020	Nou X, Kadner RJ: Coupled changes in translation and transcription during cobalamin-dependent regulation of btuB expression in Escherichia coli. J Bacteriol. 1998 Dec;180(24):6719-28.

# Drug_Target_7_HGNC_ID:
Not Available

# Drug_Target_7_HPRD_ID:
Not Available

# Drug_Target_7_ID:
2679

# Drug_Target_7_Locus:
Not Available

# Drug_Target_7_Molecular_Weight:
68408

# Drug_Target_7_Name:
Vitamin B12 transporter btuB

# Drug_Target_7_Number_of_Residues:
614

# Drug_Target_7_PDB_ID:
1UJW

# Drug_Target_7_Pathway:
Not Available

# Drug_Target_7_Pfam_Domain_Function:
PF00593	TonB_dep_Rec
PF07715	Plug

# Drug_Target_7_Protein_Sequence:
>Vitamin B12 transporter btuB precursor
MIKKASLLTACSVTAFSAWAQDTSPDTLVVTANRFEQPRSTVLAPTTVVTRQDIDRWQST
SVNDVLRRLPGVDITQNGGSGQLSSIFIRGTNASHVLVLIDGVRLNLAGVSGSADLSQFP
IALVQRVEYIRGPRSAVYGSDAIGGVVNIITTRDEPGTEISAGWGSNSYQNYDVSTQQQL
GDKTRVTLLGDYAHTHGYDVVAYGNTGTQAQTDNDGFLSKTLYGALEHNFTDAWSGFVRG
YGYDNRTNYDAYYSPGSPLLDTRKLYSQSWDAGLRYNGELIKSQLITSYSHSKDYNYDPH
YGRYDSSATLDEMKQYTVQWANNVIVGHGSIGAGVDWQKQTTTPGTGYVEDGYDQRNTGI
YLTGLQQVGDFTFEGAARSDDNSQFGRHGTWQTSAGWEFIEGYRFIASYGTSYKAPNLGQ
LYGFYGNPNLDPEKSKQWEGAFEGLTAGVNWRISGYRNDVSDLIDYDDHTLKYYNEGKAR
IKGVEATANFDTGPLTHTVSYDYVDARNAITDTPLLRRAKQQVKYQLDWQLYDFDWGITY
QYLGTRYDKDYSSYPYQTVKMGGVSLWDLAVAYPVTSHLTVRGKIANLFDKDYETVYGYQ
TAGREYTLSGSYTF

# Drug_Target_7_Reaction:
Not Available

# Drug_Target_7_Signals:
1-20

# Drug_Target_7_Specific_Function:
Involved in the active translocation of vitamin B12 (cyanocobalamin) across the outer membrane to the periplasmic space. It derives its energy for transport by interacting with the trans-periplasmic membrane protein tonB. Is also a receptor for bacteriophages BF23 and C1, and for A and E colicins

# Drug_Target_7_SwissProt_ID:
P06129

# Drug_Target_7_SwissProt_Name:
BTUB_ECOLI

# Drug_Target_7_Synonyms:
Cobalamin receptor
Outer membrane cobalamin translocator
Vitamin B12 transporter btuB precursor

# Drug_Target_7_Theoretical_pI:
5.11

# Drug_Target_7_Transmembrane_Regions:
158-165
169-178
184-195
217-227
232-248
263-277
279-296
309-325
328-337
353-369
371-381
385-400
403-417
434-443
449-458
473-490
494-509
517-529
535-550
558-572
585-596
602-614

# Drug_Target_8_Cellular_Location:
Secreted

# Drug_Target_8_Chromosome_Location:
6

# Drug_Target_8_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_8_Essentiality:
Non-Essential

# Drug_Target_8_GenAtlas_ID:
Not Available

# Drug_Target_8_GenBank_ID_Gene:
J02883

# Drug_Target_8_GenBank_ID_Protein:
180886

# Drug_Target_8_GeneCard_ID:
CLPS

# Drug_Target_8_Gene_Name:
CLPS

# Drug_Target_8_Gene_Sequence:
>339 bp
ATGGAGAAGATCCTGATCCTCCTGCTTGTCGCCCTCTCTGTGGCCTATGCAGCTCCTGGC
CCCCGGGGGATCATTATCAACCTGGAGAACGGTGAGCTCTGCATGAATAGTGCCCAGTGT
AAGAGCAATTGCTGCCAGCATTCAAGTGCGCTGGGCCTGGCCCGCTGCACATCCATGGCC
AGCGAGAACAGCGAGTGCTCTGTCAAGACGCTCTATGGGATTTACTACAAGTGTCCCTGT
GAGCGTGGCCTGACCTGTGAGGGAGACAAGACCATCGTGGGCTCCATCACCAACACCAAC
TTTGGCATCTGCCATGACGCTGGACGCTCCAAGCAGTGA

# Drug_Target_8_General_Function:
Involved in enzyme activator activity

# Drug_Target_8_General_References:
14574404	Mungall AJ, Palmer SA, Sims SK, Edwards CA, Ashurst JL, Wilming L, Jones MC, Horton R, Hunt SE, Scott CE, Gilbert JG, Clamp ME, Bethel G, Milne S, Ainscough R, Almeida JP, Ambrose KD, Andrews TD, Ashwell RI, Babbage AK, Bagguley CL, Bailey J, Banerjee R, Barker DJ, Barlow KF, Bates K, Beare DM, Beasley H, Beasley O, Bird CP, Blakey S, Bray-Allen S, Brook J, Brown AJ, Brown JY, Burford DC, Burrill W, Burton J, Carder C, Carter NP, Chapman JC, Clark SY, Clark G, Clee CM, Clegg S, Cobley V, Collier RE, Collins JE, Colman LK, Corby NR, Coville GJ, Culley KM, Dhami P, Davies J, Dunn M, Earthrowl ME, Ellington AE, Evans KA, Faulkner L, Francis MD, Frankish A, Frankland J, French L, Garner P, Garnett J, Ghori MJ, Gilby LM, Gillson CJ, Glithero RJ, Grafham DV, Grant M, Gribble S, Griffiths C, Griffiths M, Hall R, Halls KS, Hammond S, Harley JL, Hart EA, Heath PD, Heathcott R, Holmes SJ, Howden PJ, Howe KL, Howell GR, Huckle E, Humphray SJ, Humphries MD, Hunt AR, Johnson CM, Joy AA, Kay M, Keenan SJ, Kimberley AM, King A, Laird GK, Langford C, Lawlor S, Leongamornlert DA, Leversha M, Lloyd CR, Lloyd DM, Loveland JE, Lovell J, Martin S, Mashreghi-Mohammadi M, Maslen GL, Matthews L, McCann OT, McLaren SJ, McLay K, McMurray A, Moore MJ, Mullikin JC, Niblett D, Nickerson T, Novik KL, Oliver K, Overton-Larty EK, Parker A, Patel R, Pearce AV, Peck AI, Phillimore B, Phillips S, Plumb RW, Porter KM, Ramsey Y, Ranby SA, Rice CM, Ross MT, Searle SM, Sehra HK, Sheridan E, Skuce CD, Smith S, Smith M, Spraggon L, Squares SL, Steward CA, Sycamore N, Tamlyn-Hall G, Tester J, Theaker AJ, Thomas DW, Thorpe A, Tracey A, Tromans A, Tubby B, Wall M, Wallis JM, West AP, White SS, Whitehead SL, Whittaker H, Wild A, Willey DJ, Wilmer TE, Wood JM, Wray PW, Wyatt JC, Young L, Younger RM, Bentley DR, Coulson A, Durbin R, Hubbard T, Sulston JE, Dunham I, Rogers J, Beck S: The DNA sequence and analysis of human chromosome 6. Nature. 2003 Oct 23;425(6960):805-11.
15489334	Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7.
16189801	Lindner I, Helwig U, Rubin D, Li Y, Fisher E, Boeing H, Mohlig M, Spranger J, Pfeiffer A, Hampe J, Schreiber S, Doring F, Schrezenmeir J: Putative association between a new polymorphism in exon 3 (Arg109Cys) of the pancreatic colipase gene and type 2 diabetes mellitus in two independent Caucasian study populations. Mol Nutr Food Res. 2005 Oct;49(10):972-6.
1643046	Sims HF, Lowe ME: The human colipase gene: isolation, chromosomal location, and tissue-specific expression. Biochemistry. 1992 Aug 11;31(31):7120-5.
2337598	Lowe ME, Rosenblum JL, McEwen P, Strauss AW: Cloning and characterization of the human colipase cDNA. Biochemistry. 1990 Jan 23;29(3):823-8.
6691986	Sternby B, Engstrom A, Hellman U, Vihert AM, Sternby NH, Borgstrom B: The primary sequence of human pancreatic colipase. Biochim Biophys Acta. 1984 Jan 18;784(1):75-80.
8479519	van Tilbeurgh H, Egloff MP, Martinez C, Rugani N, Verger R, Cambillau C: Interfacial activation of the lipase-procolipase complex by mixed micelles revealed by X-ray crystallography. Nature. 1993 Apr 29;362(6423):814-20.

# Drug_Target_8_HGNC_ID:
GNC:2085

# Drug_Target_8_HPRD_ID:
Not Available

# Drug_Target_8_ID:
6400

# Drug_Target_8_Locus:
6pter-p21.1

# Drug_Target_8_Molecular_Weight:
11953.7

# Drug_Target_8_Name:
Colipase

# Drug_Target_8_Number_of_Residues:
112

# Drug_Target_8_PDB_ID:
Not Available

# Drug_Target_8_Pathway:
Not Available

# Drug_Target_8_Pfam_Domain_Function:
PF01114	Colipase
PF02740	Colipase_C

# Drug_Target_8_Protein_Sequence:
>Colipase
MEKILILLLVALSVAYAAPGPRGIIINLENGELCMNSAQCKSNCCQHSSALGLARCTSMA
SENSECSVKTLYGIYYKCPCERGLTCEGDKTIVGSITNTNFGICHDAGRSKQ

# Drug_Target_8_Reaction:
Not Available

# Drug_Target_8_Signals:
1-17

# Drug_Target_8_Specific_Function:
Enterostatin has a biological activity as a satiety signal

# Drug_Target_8_SwissProt_ID:
P04118

# Drug_Target_8_SwissProt_Name:
COL_HUMAN

# Drug_Target_8_Synonyms:
Not Available

# Drug_Target_8_Theoretical_pI:
7.57

# Drug_Target_8_Transmembrane_Regions:
None

# Drug_Target_9_Cellular_Location:
Secreted protein

# Drug_Target_9_Chromosome_Location:
Not Available

# Drug_Target_9_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_9_Essentiality:
Non-Essential

# Drug_Target_9_GenAtlas_ID:
PNLIP

# Drug_Target_9_GenBank_ID_Gene:
J05125

# Drug_Target_9_GenBank_ID_Protein:
339597

# Drug_Target_9_GeneCard_ID:
PNLIP

# Drug_Target_9_Gene_Name:
PNLIP

# Drug_Target_9_Gene_Sequence:
>1398 bp
ATGCTGCCACTTTGGACTCTTTCACTGCTGCTGGGAGCAGTAGCAGGAAAAGAAGTTTGC
TACGAAAGACTCGGCTGCTTCAGTGATGACTCCCCATGGTCAGGAATTACGGAAAGACCC
CTCCATATATTGCCTTGGTCTCCAAAAGATGTCAACACCCGCTTCCTCCTATATACTAAT
GAGAACCCAAACAACTTTCAAGAAGTTGCCGCAGATTCATCAAGCATCAGTGGCTCCAAT
TTCAAAACAAATAGAAAAACTCGCTTTATTATTCATGGATTCATAGACAAGGGAGAAGAA
AACTGGCTGGCCAATGTGTGCAAGAATCTGTTCAAGGTGGAAAGTGTGAACTGTATCTGT
GTGGACTGGAAAGGTGGCTCCCGAACTGGATACACACAAGCCTCGCAGAACATCAGGATC
GTGGGAGCAGAAGTGGCATATTTTGTTGAATTTCTTCAGTCGGCGTTCGGTTACTCACCT
TCCAACGTGCATGTCATTGGCCACAGCCTGGGTGCCCACGCTGCTGGGGAGGCTGGAAGG
AGAACCAATGGGACCATTGGACGCATCACAGGGTTGGACCCAGCAGAACCTTGCTTTCAG
GGCACACCTGAATTAGTCCGATTGGACCCCAGCGATGCCAAATTTGTGGATGTAATTCAC
ACGGATGGTGCCCCCATAGTCCCCAATTTGGGGTTTGGAATGAGCCAAGTCGTGGGCCAC
CTAGATTTCTTTCCAAATGGAGGAGTGGAAATGCCTGGATGTAAAAAGAACATTCTCTCT
CAGATTGTGGACATAGACGGAATCTGGGAAGGGACTCGAGACTTTGCGGCCTGTAATCAC
TTAAGAAGCTACAAATATTACACTGATAGCATCGTCAACCCTGATGGCTTTGCTGGATTC
CCCTGTGCCTCTTACAACGTCTTCACTGCAAACAAGTGTTTCCCTTGTCCAAGTGGAGGC
TGCCCACAGATGGGTCACTATGCTGATAGATATCCTGGGAAAACAAATGATGTGGGCCAG
AAATTTTATCTAGACACTGGTGATGCCAGTAATTTTGCACGTTGGAGGTATAAGGTATCT
GTCACACTGTCTGGAAAAAAGGTTACAGGACACATACTAGTTTCTTTGTTCGGAAATAAA
GGAAACTCTAAGCAGTATGAAATTTTCAAGGGCACTCTCAAACCAGATAGTACTCATTCC
AATGAATTTGACTCAGATGTGGATGTTGGGGACTTGCAGATGGTTAAATTTATTTGGTAT
AACAATGTGATCAACCCAACTTTACCTAGAGTGGGAGCATCCAAGATTATAGTGGAGACA
AATGTTGGAAAACAGTTCAACTTCTGTAGTCCAGAAACCGTCAGGGAGGAAGTTCTGCTC
ACCCTCACACCGTGTTAG

# Drug_Target_9_General_Function:
Involved in triacylglycerol lipase activity

# Drug_Target_9_General_References:
1379598	Giller T, Buchwald P, Blum-Kaelin D, Hunziker W: Two novel human pancreatic lipase related proteins, hPLRP1 and hPLRP2. Differences in colipase dependence and in lipase activity. J Biol Chem. 1992 Aug 15;267(23):16509-16.
1522902	van Tilbeurgh H, Sarda L, Verger R, Cambillau C: Structure of the pancreatic lipase-procolipase complex. Nature. 1992 Sep 10;359(6391):159-62.
2106079	Winkler FK, D'Arcy A, Hunziker W: Structure of human pancreatic lipase. Nature. 1990 Feb 22;343(6260):771-4.
2479644	Lowe ME, Rosenblum JL, Strauss AW: Cloning and characterization of human pancreatic lipase cDNA. J Biol Chem. 1989 Nov 25;264(33):20042-8.
8029213	Carriere F, Thirstrup K, Boel E, Verger R, Thim L: Structure-function relationships in naturally occurring mutants of pancreatic lipase. Protein Eng. 1994 Apr;7(4):563-9.
8406023	Sims HF, Jennens ML, Lowe ME: The human pancreatic lipase-encoding gene: structure and conservation of an Alu sequence in the lipase gene family. Gene. 1993 Sep 15;131(2):281-5.
8479519	van Tilbeurgh H, Egloff MP, Martinez C, Rugani N, Verger R, Cambillau C: Interfacial activation of the lipase-procolipase complex by mixed micelles revealed by X-ray crystallography. Nature. 1993 Apr 29;362(6423):814-20.

# Drug_Target_9_HGNC_ID:
HGNC:9155

# Drug_Target_9_HPRD_ID:
02005

# Drug_Target_9_ID:
754

# Drug_Target_9_Locus:
10q26.1

# Drug_Target_9_Molecular_Weight:
51157

# Drug_Target_9_Name:
Pancreatic triacylglycerol lipase

# Drug_Target_9_Number_of_Residues:
465

# Drug_Target_9_PDB_ID:
1N8S

# Drug_Target_9_Pathway:
Not Available

# Drug_Target_9_Pfam_Domain_Function:
PF01477	PLAT

# Drug_Target_9_Protein_Sequence:
>Pancreatic triacylglycerol lipase precursor
MLPLWTLSLLLGAVAGKEVCYERLGCFSDDSPWSGITERPLHILPWSPKDVNTRFLLYTN
ENPNNFQEVAADSSSISGSNFKTNRKTRFIIHGFIDKGEENWLANVCKNLFKVESVNCIC
VDWKGGSRTGYTQASQNIRIVGAEVAYFVEFLQSAFGYSPSNVHVIGHSLGAHAAGEAGR
RTNGTIGRITGLDPAEPCFQGTPELVRLDPSDAKFVDVIHTDGAPIVPNLGFGMSQVVGH
LDFFPNGGVEMPGCKKNILSQIVDIDGIWEGTRDFAACNHLRSYKYYTDSIVNPDGFAGF
PCASYNVFTANKCFPCPSGGCPQMGHYADRYPGKTNDVGQKFYLDTGDASNFARWRYKVS
VTLSGKKVTGHILVSLFGNKGNSKQYEIFKGTLKPDSTHSNEFDSDVDVGDLQMVKFIWY
NNVINPTLPRVGASKIIVETNVGKQFNFCSPETVREEVLLTLTPC

# Drug_Target_9_Reaction:
triacylglycerol + H2O = diacylglycerol + a carboxylate

# Drug_Target_9_Signals:
1-16

# Drug_Target_9_Specific_Function:
Not Available

# Drug_Target_9_SwissProt_ID:
P16233

# Drug_Target_9_SwissProt_Name:
LIPP_HUMAN

# Drug_Target_9_Synonyms:
EC 3.1.1.3
PL
Pancreatic lipase
Pancreatic triacylglycerol lipase precursor

# Drug_Target_9_Theoretical_pI:
6.72

# Drug_Target_9_Transmembrane_Regions:
None

#END_DRUGCARD DB04233
